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The rapid emergence of antibiotic-resistant pathogens has left mankind once 
again vulnerable to diseases caused by bacterial infections. To achieve a leading edge 
in the battle against these pathogens, novel therapeutic strategies have to be developed. 
In this project three different approaches were explored for their feasibility in the 
attenuation of bacterial virulence. The first method involves the isolation and 
characterization of an anti-microbial compound isolated from a previously unexplored 
niche; the root exudates of rice plants. Despite the inability to determine the structure 
of the inhibitor, our results suggest that the compound is a small, hydrophilic 
molecule with broad-spectrum anti-microbial activity against Gram-negative bacteria. 
In the second approach, a type III polyketide synthase from rice plant (OsPKS) 
was identified and cloned for use in combinatorial biosynthesis. In conjunction with a 
few orthologous CoA ligases, OsPKS is able to catalyze the synthesis of naringenin 
from p-coumaric acid and malonic acid precursors. The diversity of polyketides 
synthesized by OsPKS was further increased by precursor-directed biosynthesis and 
the structure-based engineering of OsPKS. Coupled with an anti-microbial screen, 
bisnoryangonin (a styrylpyrone derivative) was identified from the library that is able 
to inhibit the growth of Staphylococcus aureus and Enterococcus faecalis, with a MIC 
value of 500 M and 250 M, respectively. Further development of this lead 
compound can give rise to a more effective therapeutic agent against Gram-positive 
bacteria pathogens. 
The last approach explored the development and use of a class of quorum-
quenching enzymes known as N-acyl-homoserine lactonases (AHL-lactonases) for the 
disruption of quorum-sensing in Gram-negative pathogens. These enzymes can be 
used to prevent the activation of virulence in these bacteria, and lower the chance for 
vi 
 
the emergence of resistant strains. Directed evolution of these enzymes produced a 
few enhanced mutants with increased catalytic activity and substrate range against N-
acyl-homoserine lactones, with the best mutant having a 72-fold increase in kcat/KM 
value against 3-oxo-C12-HSL. In addition, a number of these enhanced mutants are 
now able to hydrolyze C4-HSL, a substrate that the wild-type enzymes have no 
detectable activity. The therapeutic potential of these enzymes were also demonstrated 
with their ability to disrupt the biofilm formation of Acinetobacter baumannii, a 
bacterium that is often implicated in nosocomial-based infection. The three 
independent studies carried out in this project highlight the potential of developing 
novel therapeutic strategies to produce new lead compounds, which can be used to 
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CHAPTER 1: INTRODUCTION 
 
1.1. Discovery and development of anti-microbial compounds 
Throughout history, finding the cure for human diseases has been one of the 
major goals sought after by mankind. Despite the rapid rate of antibiotic development 
since the discovery of penicillin, many bacterial infectious diseases are still 
contributing to the high mortality rate worldwide. Due to the rapid emergence of 
antibiotic-resistant pathogens, successful treatment of bacterial diseases have become 
increasingly difficult to achieve. Diseases caused by methicillin-resistant 
Staphylococcus aureus (MRSA) and multidrug-resistant (MDR) Gram-negative 
bacteria including Acinetobacter baumannii, Pseudomonas aeruginosa and 
Mycobacterium tuberculosis have become prevalent in the health care sector in recent 
years (Klevens et al, 2007; Falagas et al, 2005; Dorman and Chaisson, 2007). 
 In addition to the rise of these antibiotic-resistant “superbugs”, the problem is 
further exacerbated by a decrease in commitment by pharmaceutical companies 
towards the development of new antibiotics. The lack of novel antibiotic classes 
introduced into the market in recent years had been coined by Fischbach and Walsh 
(2009) as an “innovation gap” in the timeline of antibiotic development (Figure 1.1). 
In fact, only three new classes of antibiotics (oxazolidinones, lipopeptides and 





                  
 




In order to achieve a leading edge in the battle with microbial pathogens, the 
pressure is on mankind to continuously develop newer drugs that can target new 
strains of antibiotic-resistant pathogens. More importantly, lessons learnt from past 
experiences tell us that we need to adopt increasingly novel strategies to combat these 
pathogens. In recent years, some of these novel strategies had been described, and will 
be further elaborated upon and explored in this thesis. 
 
1.1.1.  Anti-microbial compounds derived from natural products 
Traditional approaches in the development of new anti-bacterial agents 
involved screening chemicals, natural products and even the extracts of other 
microorganisms to identify compounds with the ability to inhibit the growth of a 
target microorganism, while not having any toxic effect on human. Most of the 
antibiotics identified during the “Golden Age” of antibiotic discovery were isolated 
from natural products, including streptomycin (from Streptomyces spectabilis) and 
erythromycin (from Saccharopolyspora erythraea). 
When more antibiotics were discovered, the “rediscovery” of previously 
identified compounds became a bottleneck in the discovery process. To overcome this 
discovery hurdle, some researchers made use of bacterial strains which harbor many 
resistance genes against those commonly “rediscovered” antibiotics (Gullo et al, 
2006). By using such engineered-strains of bacteria in high-throughput screens, the 
chances of identifying a novel anti-microbial compound increases significantly. 
Since most naturally-occurring antibiotics were isolated from soil fungi, 
another alternative would be to search for inhibitory compounds derived from 
organisms living in other unexplored ecological niches, such as in marine 
environments. The marine ecosystem is a possible place to search, since the discovery 
 4 
 
of abyssomicins, a group of polycyclic antibiotics, was made from a marine 
actinomycete collected from the Japanese Sea (Bister et al, 2004). 
 
1.1.2.  Anti-microbial compounds derived from chemical modification 
When bacteria that were resistant to the first generation of antibiotics started 
emerging, synthetic tailoring was used to modify pre-existing drugs so that they were 
more resistant towards degradation. In this approach, the active component of the 
drug is untouched to preserve its activity, while other chemical groups are either 
added or removed to make them less susceptible to degradation by the resistance–
mediating enzymes. The cephalosporins had been demonstrated to be amenable to 
chemical modifications, successfully giving rise to four generations of antibiotics 
(Cefalotin, Cefuroxime, Ceftazidime and Cefepime) with increasing resistance 
towards degradation by -lactamases (Figure 1.2) (Fischbach and Walsh, 2009). 
 
                      
 
Figure 1.2. Development of cephalosporins by synthetic tailoring. The cephalosporin 




Despite the fact that synthetic tailoring appears to be successful in the 
development of new antibiotics, it only provides a short-term solution to the problem 
caused by antibiotic-resistant bacteria. Given the ease of acquiring antibiotic 
resistance through spontaneous mutations or horizontal gene transfers, antibiotics with 
similar scaffolds can easily become obsolete, often within years after deployment. As 
a result, more recent approaches in antibiotic development are targeted towards the 
identification of drugs with novel scaffolds. 
 
1.1.3.  Anti-microbial compounds derived from synthetic chemical libraries 
Besides natural products, compounds generated from chemical synthesis can 
also be used as an alternative to antibiotic discovery. Coupled with combinatorial 
synthesis, synthetic chemical libraries containing a large pool of novel compounds 
can be easily generated to screen for anti-microbial property. A few examples of 
antibiotics that were fully derived from chemical synthesis include the quinolones and 
the oxazolidinones (Figure 1.1). The advantage of using synthetic antibiotics with 
novel scaffolds is that they usually have a novel mechanism of action, and hence the 
rate of the emergence of antibiotic-resistant pathogens is lowered. The quinolones, 
discovered to inhibit bacterial gyrases, is a good example where enzymes from a 
previously unidentified cellular process can become a successful and viable drug 
target. 
 
1.1.4.  Anti-virulence strategies to control bacterial-mediated infection 
Anti-bacterial compounds developed from natural products, chemical 
modification or synthetic libraries, usually target the inhibition of a particular cellular 
process, such as the synthesis of bacterial cell wall or proteins. Despite the 
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effectiveness of these strategies in the treatment of diseases, these methods also serve 
as an ideal platform for the selection of drug-resistant pathogens. To overcome this 
problem, some scientists have suggested using drugs capable of targeting the 
virulence of the bacteria instead of growth (Rasko and Sperandio, 2010). By 
preventing the virulence of the bacteria, there will be no selection for resistant strains 
against anti-virulence drugs. Some potential anti-virulence strategies include 
inhibiting the production of bacteria toxins, blocking the adhesion of bacteria to host 
cells and disrupting the regulation of virulence gene expression, such as the Type III 
Secretion Systems and quorum sensing. 
 
1.1.5.  Development of the next-generation anti-microbial therapeutics 
The scope of this thesis is targeted towards the development of novel anti-
microbial therapeutics that could potentially be used to treat bacterial-mediated 
diseases. As mentioned earlier, new classes of anti-microbial compounds can be 
discovered by searching through previously under-explored niches. Hence, in the first 
part of this thesis, an attempt to isolate and characterize an anti-microbial compound 
from the root exudates of rice plants will be described. Next, a library of unnatural 
compounds was generated with the aid of a class of enzymes known as the polyketide 
synthases (PKSs); these compounds were subsequently screened for anti-microbial 
activity. Lastly, the feasibility of using N-acyl homoserine lactonases (AHL-
lactonases) to inhibit the biofilm formation of Gram-negative bacteria, by disrupting 






1.2. Isolation of anti-microbial compounds from natural products 
 Most of the antibiotics discovered during the early days were often isolated 
from natural products, usually from various species of plants, fungi and bacteria. 
Production of these chemicals was often evolved as a strategy to provide a selective 
advantage to the growth of the organism, usually through the mediation of complex 
interactions with other organisms present in the same ecological niche. Such 
interactions can be positive, providing a symbiotic relationship between both 
organisms. However, most of the time, the interaction is negative so as to prevent the 
growth of other organisms that would otherwise compete for the availability of space 
and nutrients. In plants, the secreted compounds can also protect the host against 
potential parasites or pathogens. 
 
1.2.1.  Production of secondary metabolites in plants 
The route of natural products secretion in plants can occur through the aerial 
parts of the plants into the phyllosphere or through the roots into the rhizosphere. 
Housing a wide range of microorganisms, including numerous opportunistic plant-
pathogens, the rhizosphere is highly dynamic, often involved in a constant exchange 
of nutrients and other secondary metabolites between the plant and its surrounding 
environment. Ironically, the “rhizosphere effect” suggests that secretion of nutrients 
into the rhizosphere provides the opportunity for many microbes (including pathogens) 
to initiate colonization of the host organism (Bais et al, 2006). Thus, some of these 
secondary metabolites are secreted as a countermeasure to prevent the colonization of 
the plant’s rhizosphere by harmful microorganisms. 
The root exudates of most plants encompass a wide of range of compounds 
that differ greatly in molecular weight and chemical property. Most of these 
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compounds include various forms of nutrients such as sugars, amino acids, organic 
acids, fatty acids, sterols, growth factors and vitamins (Bertin et al, 2003). Other more 
interesting secondary metabolites that had been identified include derivatives of 
alkaloids, flavonoids, and terpenoids, which are known to possess a wide range of 
pharmacological activities, such as anti-microbial and anti-cancer properties. A few of 
these compounds were listed in Table 1.1. 
 




1.2.2.  Production of phytoalexins in Oryza sativa 
Oryza sativa (or commonly known as rice) is a cereal plant with major global 
importance as it is one of the main staple foods that is used to feed a large portion of 
the world’s human population. Being domesticated and cultivated for thousands of 
years, it is interesting to note that O. sativa seems to possess an intricate system of 
self-defense against infection from many soil-borne bacteria. For example, among 
many of the diseases found in rice, only a few of them are caused by bacteria. This 
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includes Burkholderia glumae and Xanthomonas oryzae, which are the causative 
agents of bacterial grain rot and bacterial blight, respectively (Ham et al, 2011; White 
and Yang, 2009). 
One form of defense used by O. sativa to combat microbial pathogens is 
through the secretion of phytoalexins. These compounds are usually synthesized in 
the plant upon exposure to microorganisms and then secreted out of the roots into the 
rhizosphere. In O. sativa, a number of such compounds had been characterized (Table 
1.2). Most of these compounds possess anti-fungal activity, with the exception of 
momilactones, which also display allelopathic activity towards the growth of various 
herbs and weeds (Chung et al, 2005). Interestingly, none of these compounds had 
been demonstrated to possess any anti-bacterial activity, suggesting that some other 
unknown compounds might be involved in mediating the plant’s defense against 
bacterial pathogens. 
 





1.2.3.  Mechanism of bacterial non-host resistance in plants 
Despite major differences between the physiology of plants and animals, 
certain bacterial pathogens are capable of initiating infection in both plant and animal 
hosts. This dual host phenomenon was first discovered in 1995 by Rahme et al, who 
identified a special strain of P. aeruginosa capable of infecting Arabidopsis thaliana 
and mouse. Since then, many other bacterial pathogens such as S. aureus and 
Enterococcus faecalis were found to display this characteristic (Prithiviraj et al, 2005). 
These findings are important because use of plants as models for the study of animal 
pathogenesis can circumvent the inherent limitations associated with the use of animal 
models. For example, working with an animal infection model can be tedious and 
time-consuming, while high-throughput screening of plants can be easily carried out. 
Recently, Burkholderia pseudomallei (a causative agent of melioidosis) had 
been shown to be capable of infecting tomato plants but not rice plants (Lee et al, 
2010). One of the reasons for this observed non-host resistance in rice plants could be 
attributed to the inability of the pathogen to overcome the plant’s defense machinery 
(Thordal-Christensen, 2003). Such defense include the presence of pre-formed 
barriers such as the plant’s cell wall or the release of phytoanticipins which are 
secondary metabolites constitutively produced by the plant. The other type of defense 
is activated only in response to pathogenic infection, which includes the production 
and release of phytoalexins. Given the low occurrence of bacterial pathogen capable 
of initiating infection in O. sativa, it seems plausible that some type of anti-bacterial 
secondary metabolites might be released by these plants into the rhizosphere, either in 





1.2.4.  Characterization of anti-microbial compound(s) from plant root exudates 
In order to characterize potential anti-microbial compound(s) from the root 
exudates of rice plants, various biochemical methods can be used to purify and isolate 
the compound(s) from other secondary metabolites present in the root exudates. As 
depicted by Bais et al (2006), a typical methodology used for the characterization of 
bioactive compounds from plant root exudates involves: (i) collection of root exudates, 
(ii) organic extraction of crude exudates, (iii) analytical separation of organic extract 
and (iv) use of an appropriate bioassay that allows the user to track the active 
compound(s) throughout the course of the purification. 
Collection of plant root exudates should be carried out under a sterile, in vitro 
environment to minimize batch to batch variation, which is usually present in samples 
collected directly from soil (Huang et al, 2003). The choice of organic solvent used 
for the extraction depends on the property of the compound to be isolated. As a rule of 
thumb, polar compounds should be extracted with solvents of high polarity (E.g. 
methanol, ethyl acetate), while hydrophobic compounds should be extracted with non-
polar solvents (e.g. hexane, diethyl ether). Other properties of the solvent that can 
affect the process of the extraction include cost, toxicity, boiling point and solubility 
in water. Solvents with lower boiling points are often preferred since the sample can 
be concentrated easily with a rotary evaporator. To facilitate liquid-liquid extraction, a 
solvent that is immiscible with water should be used. 
High performance liquid chromatography (HPLC) is widely used for the 
separation of natural products, due to its versatility and ability to detect many 
allelochemicals when coupled with an ultraviolet (UV) detector. Unlike in gas 
chromatography where the compound has to be volatile, the only requirement for 
HPLC separation is that the sample needs to be soluble in the mobile phase. 
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Depending on the property of the compound, various types of HPLC methods can be 
used, which include gel filtration, ion-exchange and reverse-phase chromatography. 
During various stages of purification, it is important to use an appropriate bioassay for 
the tracking of the compound of interest. The disk diffusion test, macro- and micro-
dilution assays are methods commonly used for the detection of anti-microbial 
activity. 
 
1.3. Combinatorial biosynthesis of novel anti-microbial polyketides 
Combinatorial chemistry was once applauded by many as a technique that has 
the capability of revolutionizing the entire drug discovery process, due to its utility in 
the construction of a large library of unique chemical compounds within a short 
timeframe. However, this technique has met with its detractors in recent years, mainly 
due to its inability to generate libraries with sufficient chemical diversity; a lack of 
new lead compounds that are produced over the years, when compared to traditional 
approaches, has resulted in skepticism over the utility of the technique in the drug 
delivery process (Feher and Schmidt, 2003). More recently, combinatorial 
biosynthesis of natural products has been proposed as an alternative to combinatorial 
chemistry; this “new” method is billed to be capable of generating compound libraries 
with sufficient diversity and complexity that is not achievable by chemical synthesis 
(Pollier et al, 2011). This approach involves the use of a cascade of enzymes, 
identified from various organisms, to synthesize or modify new products through a 
series of biotransformations within a cell. In this study, combinatorial biosynthesis of 





1.3.1.  Synthesis of polyketides by type III polyketide synthases 
Polyketides encompass a group of natural products with diverse structural 
scaffolds and possess a wide range of interesting biological and pharmacological 
properties (Figure 1.3). Their importance in the pharmaceutical industry can be 
illustrated by the large number of polyketide-based drugs that have been released in 
the market over the years, with more than 20 known polyketides that are successfully 
commercialized (Weissman and Leadlay, 2005). These compounds are mainly found 
in microbes and plants, and are synthesized from acyl-CoA precursors by a class of 
enzymes known as polyketide synthases (PKSs). Due to the similarity in the overall 
fold and reaction mechanism between a PKS and a fatty acid synthase (FAS), PKSs 




Figure 1.3. Chemical structure and biological activity of selected polyketides. 
 
To date, three different classes of PKS have been discovered; these enzymes 
can be differentiated from one another based on their substrate requirements and 
reaction mechanisms. Type I PKSs are typically large, modular protein complexes 
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which catalyze the non-iterative condensation of acyl-CoA subunits to form 
polyketides (Figure 1.4). Each module of the complex comprises of various domains 
that catalyze a unique set of modification to the growing polyketide chain. The 
polyketide is then transferred between modules with the aid of an acyl carrier protein 
(ACP) that is covalently linked to the polyketide through a thioester bond. Type II 
PKSs are also multienzyme complexes that utilize a linkage between an ACP and the 
polyketide. However, the reactions catalyzed by these enzymes are iterative, involving 
multiple rounds of repeated condensation with the acyl-CoA precursors. Type III 
PKSs are unique in the sense that they are much smaller (relative to Type I and II 
PKSs), involving only a single polypeptide enzyme to catalyze the iterative 
condensation reaction. In addition, these enzymes do not require the help of ACP for 
the transfer of the growing polyketide chain. 
Type III PKSs are known for their ability to catalyze a complex reaction 
within a single active site of the enzyme. Studies have shown that the identities of 
certain active site residues are critical for mediating the termination of the polyketide 
extension, and alteration of these residues can affect the identity of the product 
formed (Austin and Noel, 2003; Abe and Morita, 2010). In addition, the inherent 
substrate promiscuity of these enzymes also allows them to accept unnatural 
substrates, producing a wide range of compounds with novel scaffolds. Hence, type 
III PKSs are ideal, molecularly tractable candidates for use in combinatorial 





Figure 1.4. Summary of reaction mechanisms of Type I, II and III PKSs (Adapted 
from Shen, 2003). Each polyketide synthase comprise of various domains that are 
involved in catalyzing a particular reaction. Reactions catalyzed by Type I PKS are 
non-iterative and ACP-dependent. Reactions of Type II PKS are iterative and ACP-
dependent. Reactions of Type III PKS are also iterative but does not require an ACP 
for the attachment of the growing polyketide chain. (AT) Acyl transferase. (ACP) 
Acyl carrier protein. (KS) Ketosynthase. (KR) Ketoreductase. (DH) Dehydratase. 
(CoA) Coenzyme A. 
 
1.3.2. Chalcone synthase superfamily of the plant type III polyketide synthases 
Unlike type I and type II PKSs, which can only be found in microbes, type III 
PKSs can be found in both microbes and plants. In fact, the first group of type III 
PKSs that were discovered are members of the plant chalcone synthase (CHS) 
superfamily. These enzymes are involved in the biosynthesis of flavonoids, a major 
class of secondary metabolites present in plants. Components of the flavonoid 
biosynthetic pathway can be classified into (i) enzymes that convert phenylalanine (or 
tyrosine) into p-coumaroyl-CoA, (ii) enzymes involved in the synthesis of the 
flavanone scaffold, and (iii) enzymes involved in the modification of the flavanone 
scaffold to generate various flavonoid derivatives (Figure 1.5). Given the importance 
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of these enzymes in the production/modification of flavonoids, many of them have 
been used in combinatorial biosynthesis (Horinouchi, 2009). 
CHS catalyzes the most complex and crucial reaction of the entire flavonoid 
biosynthetic pathway. The reaction includes an acyltransferase activity that loads p-
coumaroyl-CoA onto the active site of the enzyme, and a decarboxylase activity to 
activate the malonyl-CoA extenders. The activated acetyl-CoA anion will be 
incorporated into growing polyketide chain, and the reaction will be repeated 
iteratively until a tetraketide is formed. Upon chain termination, the cyclase activity of 
the enzyme converts the linear tetraketide into a chalcone; it was previously 
demonstrated that the intramolecular cyclization of the chalcone into flavanone can be 
achieved spontaneously without the aid of a chalcone isomerase (CHI), albeit at a 
much lower rate (Jez and Noel, 2002). 
The first crystal structure of CHS was elucidated using recombinant Medicago 
sativa (Alfafa) CHS (MsCHS), which revealed the presence of a catalytic triad 
consisting of Cys164, His303 and Asn336 residues within the active site of the 
enzyme (Ferrer et al, 1999). Cys164 was found to be important in maintaining a 
thioester linkage with the substrates, while His303 and Asn336 are involved in the 
formation of an oxyanion hole to stabilize the carbonyl oxygen of the CoA substrates 
during formation of the tetrahedral intermediate (Austin and Noel, 2003). In addition 
to the catalytic triad, several other residues (Thr132, Ser133, Thr194, Thr197, Phe215, 
Gly256, Phe265 and Ser338, respectively) within the active site pocket were also 
implicated in determining the specificity of product formation. These residues are 
conserved in CHSs but not in other type III PKSs, suggesting a role in controlling the 






                          
 
Figure 1.5. Flavonoid biosynthetic pathway in plants (Adapted from Ferrer et al, 2008). (PAL) Phenylalanine ammonia-lyase. (C4H) Cinnamic 
acid 4-hydroxylase. (4CL) p-coumaroyl:CoA ligase. (CHS) Chalcone synthase. (AURS) Aureusidin synthase. (CHI) Chalcone isomerase. (FNS) 
Flavone synthase. (IFS) Isoflavone synthase. (F3H) Flavanone 3-hydroxylase. (F3’H) Flavonoid 3’ hydroxylase. (F3’5’H) Flavonoid 3’5’ 
hydroxylase. (DFR) Dihydroflavonol 4-reductase. (LCR) Leucoanthocyanidin reductase. (ANS) Anthocyanidin synthase. 
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1.3.3.  Strategies for the combinatorial biosynthesis of unnatural polyketides 
Combinatorial biosynthesis is a field that is currently under rapid development 
and various strategies are being explored for their effectiveness in producing a large 
pool of structurally diverse and novel compounds. The most direct and traditional 
approach of combinatorial biosynthesis involves the use of a bacteria host to harbor 
genes from various organisms that are involved in either the synthesis or modification 
of a polyketide. For example, E. coli can be engineered to contain all the enzymes 
from the flavonoid biosynthesis pathway, which will lead to the production of 
flavonoid derivatives when the cells are fed with phenylalanine (Figure 1.5). The 
main disadvantage of this approach is the lack of sufficient diversity within the pool 
of biosynthesized compounds. 
A second approach of combinatorial biosynthesis is known as precursor-
directed biosynthesis; this method utilizes the inherent substrate promiscuity of PKSs 
to produce novel polyketides from a range of unnatural substrates, and includes the 
use of substrate derivatives which contain one or more additional functional groups on 
the substrate. As demonstrated by Katsuyama et al (2007), the use an assembly of 
biosynthetic enzymes with a pool of unnatural substrates resulted in the production 
polyketides including 36 novel derivatives. 
More recently, it was discovered that the diversity of polyketides can be 
further increased with structure-based protein engineering. This approach relies on the 
complexity of the PKS reaction and knowledge of the active site residues that are 
capable of directing the specificity of the PKS reaction (Figure 1.6). Although a 
typical CHS reaction involves the synthesis of a tetraketide product, that is then 
cyclized to form naringenin, mutagenesis studies have revealed that a G256F mutation 
in MsCHS resulted in the formation of a triketide product using p-coumaroyl-CoA 
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and malonyl-CoA as starter CoA and extender CoA, respectively (Jez et al, 2001). 
The same group also demonstrated that an MsCHS, engineered to contain eight 
mutations from the pine stillbene synthase (STS), is able to catalyze the synthesis of 
resveratrol instead of naringenin (Austin et al, 2004). These findings suggest that 
appropriate changes to the active site residues can alter the product profile of type III 
PKSs, and can be used as a strategy to increase the diversity of products formed by 
combinatorial biosynthesis. 
 
   
 
Figure 1.6. Possible side-products generated from the CHS reaction. (Red) Reduction 
in the number of malonyl-CoA condensation can lead to the formation of diketide or 
triketide products. (Green) Different mode of tetraketide cyclization can lead to the 
formation of naringenin chalcone, resveratrol and p-coumaroyltriacetic acid. 
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1.4. Development of quorum-quenching lactonases as an anti-virulence strategy 
Due to the rapid emergence of antibiotic-resistant pathogens, the development 
of new generations of anti-microbial therapeutics should be targeted towards the use 
of anti-virulence strategies. Among the list of possible virulence targets found in 
many bacterial pathogens, inhibition of the quorum-sensing pathways in Gram-
negative bacteria appears to be a well-received strategy that awaits further 
development. This is due to the importance of quorum-sensing in controlling the 
expression of virulence genes in many bacteria during pathogenesis, which in some 
cases can lead to the formation of biofilms (Antunes et al, 2010). Moreover, this 
pathway is highly conserved in Gram-negative bacteria, and hence, the development 
of a successful therapeutic would most likely be broad-spectrum in nature. 
 
1.4.1.  Mechanism of quorum-sensing in bacteria 
Quorum-sensing is a mechanism used by many different bacteria to coordinate 
cell-density-dependent behavior through the targeted expression of selected genes. 
This phenomenon was first discovered in Vibrio fischeri, a marine bacterium that 
produces a bioluminescent signal after a particular cellular density is reached 
(Nealson et al, 1970). Since the bacterium is in a symbiotic relationship with 
numerous species of marine organisms, production of the bioluminescent signal is 
important for providing the bacterium’s hosts with a counter-illumination camouflage 
under the moonlight (Young and Roper, 1976). 
Coordinated production of the bioluminescent signal in V. fischeri is mediated 
by a Lux operon consisting of the LuxCDABE genes that are involved in the 
production of the bioluminescent signal and the LuxR/LuxI genes that are involved in 
the sensing of cellular density (Figure 1.7). At a low cell density, basal level of N-(3-
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oxohexanoyl)-homoserine lactone (3-oxo-C6-HSL) synthesis is catalyzed by the LuxI 
synthase using precursors S-adenosyl methionine (SAM) and acyl-acyl carrier protein 
(acyl-ACP). As the cell density increases, the concentration of 3-oxo-C6-HSL will 
reach a threshold concentration where they will bind onto the receptor encoded by 
LuxR. The 3-oxo-C6-HSL-bound LuxR acts as a transcriptional activator that is 
capable of driving the expression of various genes that are involved in mediating the 
quorum-based phenotypes. In V. fischeri, activation of the LuxCDABE genes by the 




Figure 1.7. Mechanism of quorum-sensing in V. fischeri. Basal level of LuxI synthase 
is expressed and catalyze the synthesis of 3-oxo-C6-HSL from S-adenosyl-methionine 
and acyl-ACP. Once a threshold concentration of 3-oxo-C6-HSL is reached, it will 
bind onto the constitutively-expressed LuxR receptor. Bound-LuxR activates the 
expression of more LuxI and the LuxCDABE genes to produce the bioluminescent 
signal. 
 
Ever since the discovery of quorum-sensing in V. fischeri, this signaling 
pathway was found in many bacterial species utilizing other types of quorum 
molecules for quorum sensing (Waters and Bassler, 2005; Williams et al, 2007). A list 
of these compounds is shown in Figure 1.8. Among these compounds, the N-acyl-
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homoserine lactones (AHLs) and autoinducer peptides (AIPs) comprise two of the 
major groups of quorum signals that are used extensively in Gram-negative and 




Figure 1.8. Chemical structure of molecules used in quorum-sensing. (AHL) N-acyl-
homoserine lactone. (A-factor) 2-isocapryloyl-3-hydroxy-methyl--butyrolactone. 
(AI-2) furanosyl-borate ester. (PQS) 2-heptyl-3-hydroxy-4-quinolone. (AIP-I) 
autoinducing peptide-I (PAME) hydroxy-palmitic acid methyl ester. (DSF) diffusible 
signal factor (methyl dodecenoic acid). 
 
Many different derivatives of AHLs are found in nature and they differ mainly 
by the length and oxidation state of the acyl chain. The length of the acyl chain can 
typically range from 4 to 18 carbons (C4 to C18), while the C3 position can be 
modified chemically with either a hydroxy- or keto-functional group (3-hydroxy-acyl-
HSL or 3-oxo-acyl-HSL, respectively). In many bacterial pathogens, synthesis and 
detection of their corresponding AHLs are mediated by members of the respective 
LuxI and LuxR protein families, where they share a high sequence similarity with the 
proteins that were first discovered in V. fischeri (Table 1.3). In these bacteria, the 
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quorum-sensing pathway is often used to control the activation of the respective 
virulence phenotypes during pathogenesis (Williams et al, 2007). 
 




1.4.2.  Strategies to inhibit quorum-sensing pathway 
Different strategies to inhibit the AHL-dependent quorum-sensing pathway in 
bacterial pathogens have been proposed (Dong et al, 2007). These strategies can be 
categorized under the use of inhibitors to block the synthesis of the quorum signal by 
LuxI-like proteins, the binding of the quorum signal by LuxR-like proteins, and the 
use of AHL-degrading enzymes to convert the signaling molecules into inactive forms 
(Figure 1.9). 
Reports on the known inhibitors of the LuxI-like proteins are limited, which 
include the substrate analogue of SAM (S-adenosyl-homocysteine) and the structural-
mimic of AHL (amidocyclohexenone) (Parsek et al, 1999; Chung et al, 2011). On the 
other hand, more studies were conducted on the identification of inhibitors capable of 
targeting the LuxR-like proteins, presumably due to a lack of specificity for the 
inhibitors of LuxI-like proteins (inhibitors of LuxI-like proteins would probably target 
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other essential enzymes that utilize SAM or acyl-ACP as substrates). A few 
compounds that had been identified include various AHL-analogues that are either 
naturally-occurring (halogenated furanones) or synthetic (amidophenol and benzyl-
homoserine lactone) (Bjarnsholt and Givskov, 2007; Uroz et al, 2009). 
 
 
Figure 1.9. Various strategies of inhibiting AHL-dependent quorum-sensing. (i) 
Inhibitors of the LuxI-like proteins: S-adenosyl-homocysteine and 
amidocyclohexenone. (ii) Inhibitors of the LuxR-like proteins: Halogenated furanone, 
benzyl-homoserine lactone and amidophenol. (iii) AHL-degrading enzymes: AHL-
lactonases, decarboxylases, deaminases or acylases. 
 
It is known that many bacteria species can produce AHL-degrading enzymes 
to mediate the inactivation of the quorum-sensing pathway when it is not required. In 
some bacteria, these enzymes are produced as a means to prevent the proliferation of 
other organisms so as to reduce competition. As pointed out by Dong and Zhang 
(2005), degradation of an AHL molecule can be achieved by cleaving either one of 
the four chemical bonds in AHL with an appropriate enzyme (Figure 1.9). Among 
these possible cleavage reactions, two reactions were found to be catalyzed by 
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naturally occurring enzymes, the AHL-acylases and AHL-lactonases, respectively. 
Expression of these enzymes in P. aeruginosa had been demonstrated to be able to 
attenuate the quorum-sensing phenotypes of the bacteria (Reimmann et al, 2002; Lin 
et al, 2003). 
 
1.4.3.  Convergent evolution of AHL-lactonases 
The AHL-lactonases comprise of three different groups of enzymes that share 
remarkable differences in overall structure, active site architecture and substrate 
preferences (Figure 1.10). The first AHL-lactonase that was discovered was AiiA 
from Bacillus thuringiensis; this enzyme is part of a group of enzymes from the 
metallo--lactamase superfamily (Liu et al, 2005). This superfamily of enzymes 
typically catalyzes the hydrolysis of various forms of esters and possesses a bimetallic 
center coordinated by five histidine and two aspartate residues. The second group of 
AHL-lactonases belongs to the phosphotriesterase-like lactonases (PLLs) (Elias et al, 
2008). These enzymes are members of the amidohydrolase superfamily and bear a 
(/)8-barrel fold. Like the metallo--lactamases, the active site of the enzymes 
contain two metal ions that are coordinated by four histidines, an aspartate and a 
carboxylated lysine residue. Lastly, the serum paraoxonases (PONs) comprise of a 
group of mammalian enzymes that also possess AHL-lactonase activity (Khersonsky 
and Tawfik, 2005). These enzymes bear a six-bladed -propeller fold and use Ca2+ in 
its active site for catalysis; Ca
2+
 is coordinated by three asparagines, one glutamate 








                 
 
Figure 1.10. Structural differences between the three families of AHL-lactonases. (Top) Ribbon diagram representation of various AHL-
lactonases. -helices are colored blue and -sheets are colored yellow. (Bottom) Active site architecture of various AHL-lactonases. (From left) 
AiiA (metallo--lactamases, PDB code 2A7M), SsoPox (phosphotriesterase-like lactonases, PDB code 2VC5) and PON1 (serum paraoxonases, 
PDB code 1V04)  
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Given the differences in the overall structure and active site architecture of 
members of each of the AHL-lactonase family, it is believed that the activity of these 
enzymes had evolved from different ancestors through convergent evolution (Elias 
and Tawfik, 2012). In the pre-historical era dominated by microorganisms, one can 
imagine the importance of having enzymes with AHL-lactonases activity, as they can 
provide their hosts with an advantage in a battle that is fought with quorum signals. 
To provide additional insights on how various proteins had evolved from its earlier 
progenitors, additional members of various enzyme superfamilies should be further 
characterized, both functionally and structurally. 
 
1.4.4.  (/)8-barrel fold and the amidohydrolase superfamily 
The (/)8-barrel is a common protein fold found in many enzymes. As 
observed in the structure of SsoPox, a typical (/)8-barrel fold consists of eight 
repeating units of an -helix and a -strand, separated by random loops (Figure 1.10). 
The arrangement of these structural units provide the (/)8-barrel fold with great 
stability while the enzyme’s activity and substrate specificity are conferred by specific 
residues on the interconnecting -loops along one face of the barrel. With these 
features, the (/)8-barrel is an ideal scaffold for the engineering of enzymes with 
new activity or substrate specificity (Sterner and Höcker, 2005). 
The amidohydrolase superfamily constitute a sub-group of enzymes that 
possess the (/)8-barrel fold. Common features of this family of enzymes include a 
high degree of structural similarity (despite low sequence similarity) as well as 
conservation of the active site architecture. These enzymes usually catalyze hydrolytic 
reactions on various substrates, utilizing either a mononuclear or binuclear metallic 
center within the active site of the enzyme to coordinate the nucleophilic attack of a 
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water molecule on the respective substrates. With the exception of phophotriesterase 
(PTE) which catalyzes the cleavage of a P–O bond, other members of the 
amidohydrolase superfamily catalyze the cleavage of C–N bonds (Seibert and Raushel, 
2005). 
After the recent discovery that PTE possess promiscuous lactonase activity, it 
was suggested that PTE might have been evolved from an ancestral lactonase 
(Roodveldt and Tawfik, 2005). In addition, the BLAST (Basic Local Alignment 
Search Tool) search performed by Afriat et al (2006) revealed that a group of PTE-
like enzymes (PLLs) can be found in many different organisms; the authors went on 
to demonstrate that two of these PLLs possess lactonase activity. With the inherent 
functional plasticity of the (/)8-barrel fold, we believe that the PLLs with their 
associated lactonase activity will serve as excellent starting points for the 





CHAPTER 2: TOWARDS THE ISOLATION AND CHARACTERIZATION 




Natural products from animals, plants and microorganisms are known to 
possess interesting biological activities. The observations made by Lee et al (2010) 
during the establishment of a plant-based infection model for B. pseudomallei 
suggested the existence of an anti-microbial compound present in the root exudates of 
Oryza sativa. Isolation and characterization of this compound can potentially lead to 
the development of a drug for treating melioidosis. 
Melioidosis is an infectious disease caused by B. pseudomallei and is endemic 
in various regions of Southeast Asia and Northern Australia (Sprague and Neubauer, 
2004). Each year, the disease caused a significant rate of morbidity and mortality 
within the endemic regions. The problem is further exacerbated by the intrinsic 
resistance of the bacteria against many commonly used antibiotics, making treatment 
of the disease difficult. Studies have shown that part of the bacterial resistance is 
mediated by the presence of class A, C and D -lactamases that break down penicillin 
and even the third generation cephalosporin such as ceftazidime (Niumsup and 
Wuthiekanun, 2002). In addition, a number of the bacterial efflux pumps (AmrAB-
OprA and BpeAB-OprB) can also facilitate the transport of various antibiotics such as 
the aminoglycosides and macrolides out of the cell (Moore et al, 1999; Chan et al, 
2004). Hence, the development of new antibiotics to treat melioidosis may circumvent 
the problem of infection caused by antibiotic-resistant bacteria. 
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As B. pseudomallei is a risk group 3 microorganism that requires a biosafety 
level 3 (BSL-3) facility for handling and containment, it was not used in this project. 
Instead, Burkholderia thailandensis, a bacterium that is closely related to B. 
pseudomallei, was used. The major differences between B. pseudomallei and B. 
thailandensis include the inability of B. pseudomallei to assimilate L-arabinose and 
the higher dose required for B. thailandensis to cause infection in animal models 
(Smith et al, 1997). Since it had been demonstrated that B. thailandensis can be used 
as a model system for the studies of virulence factors in B. pseudomallei (Haraga et al, 
2008), B. thailandensis can also be used as a surrogate organism to test our 
compounds on in our attempt to identify the anti-microbial compound from the root 
exudates of rice plants. 
 
2.2. Materials and methods 
2.2.1.  Sterilization and germination of Arabidopsis, tomato and rice seeds 
Rice seeds (Oryza sativa var. Indica) were provided as a kind gift from Dr Yin 
Zhong Chao (Temasek Life Sciences Laboratory). The seeds of Arabidopsis thaliana 
line Landsberg erecta (Lehle Seeds), tomato (Solanum lycopersicum season red F1 
hybrid, Known-You Seed) and rice were sterilized by washing them in 70% ethanol 
for 1 min and then transferred to 15% bleach for 15 mins. After that, the seeds were 
rinsed with sterile water three times, for about 1 min each with shaking. The seeds 
were then dried on a sterile paper towel. 
For the preparation of the plant medium, 4.4 g of Murashige and Skoog (MS) 
medium including Nitsch vitamins (Duchefa) and 30g of sucrose (Duchefa) were 
dissolved in 1 L of water and the pH was adjusted to 5.8 with 1 M NaOH. 8 g of plant 
agar (Duchefa) was then added and the mixture was sterilized by autoclaving. About 
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80 ml of plant medium was then poured into each Magenta GA7 box (Bioworld) and 
cooled at room temperature for the agar to solidify. 
To germinate the sterilized plant seeds, the seeds were gently pushed down 
below the surface of the MS agar using a sterile forcep. The boxes were then 
transferred to a dark chamber and incubated for three days. After the seeds had 
germinated, they were transferred to a growth room with a photoperiod of 16 h 
daylight and 8 h darkness. 
 
2.2.2.  Collection of root exudates and plate-count assay 
14-day-old plantlets were transferred into a 50 ml falcon tube containing 5 ml 
of liquid MS medium (without plant agar and sucrose) and incubated in the growth 
chamber with a photoperiod of 16 h daylight and 8 h darkness with gentle shaking at 
100 rpm. For Arabidopsis, only 1 ml of MS medium was used as it is much smaller 
than tomato and rice plants. The plants were removed from the medium after 2 days 
of incubation. 
Log-phase B. thailandensis, A. baumannii, Escherichia coli, P. aeruginosa and 
S. aureus were prepared by inoculating an overnight culture of the bacteria in fresh 
Luria-Bertani (LB) medium and incubated at 37C with shaking for 2 h. For the plate-
count assay, an inoculum of 1 × 10
4
 CFU/ml were added to either fresh MS medium 
or the rice spent-medium and incubated at 37C with shaking for 6 h. 10 l of each 
sample was removed and serially diluted in phosphate-buffered saline (PBS) before 






2.2.3.  Acid and base hydrolysis of rice spent-medium 
For acid and base hydrolysis, 40 mM of HCl or NaOH were added to the 
samples and incubated at room temperature for 3 h before they were neutralized with 
an equal concentration of NaOH or HCl, respectively. The plate-count assay was then 
carried out on the treated samples as described above. 
 
2.2.4.  Sample filtration with centrifugal filter unit 
Filtration was carried out by centrifuging 5 ml of the sample through a 3 kDa 
Amicon centrifugal filter unit (Millipore) at 5000 rpm. The filtrate was used directly 
for the assay while the retentate was re-dissolved in 5 ml of liquid MS medium before 
it was used for the assay. 
 
2.2.5.  Liquid-liquid organic extraction of rice spent-medium 
Hexane, diethyl ether, chloroform and ethyl acetate were purchased from 
Sigma. Organic extraction was performed by mixing 5 ml of sample with 5 ml of 
organic solvent in a separatory funnel and shaked vigorously for 5 min. The aqueous 
phase was dried by lyophilization and re-dissolved in 5 ml of sterile water. The 
organic phase was evaporated to dryness using a vacuum concentrator and re-
dissolved in 5 ml of liquid MS medium. Both the extracts were then used directly for 
the assay. 
 
2.2.6.  Solid-phase extraction of rice spent-medium 
Solid-phase extraction was carried out using Oasis HLB, MCX and MAX 
30m 1cc/30mg cartridges (Waters). All the cartridges were first equilibrated with 1 
ml of methanol followed by 1 ml of water. 5 ml of sample was then loaded into the 
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cartridges and elution was carried out using 1 ml of methanol for the HLB cartridge. 
For the MCX cartridge, 5% ammonium hydroxide in methanol was used to elute the 
sample while 2% formic acid in methanol was used for the MAX cartridge. All the 
flowthroughs and eluents were lyophilized and re-dissolve in 5 ml of sterile water or 
liquid MS medium, respectively. The samples were then tested for inhibition using the 
plate-count assay. 
 
2.2.7.  Mass spectrometry analysis of rice spent-medium 
Mass spectrometry of MS medium and rice spent-medium including data 
collection and analysis were performed by Ms Cheong Wei Fun and Dr. Shui Guang 
Ho (Lab of Prof. Markus Wenk, National University of Singapore).  
 
2.3. Results and discussion 
2.3.1.  Development of an assay to detect growth inhibition in rice spent-medium 
The lack of B. thailandensis growth in the spent-medium of rice plants 
observed by Lee et al (2010) suggested that anti-microbial compound(s) might be 
secreted by these plants into the medium. To confirm this observation, Arabidopsis, 
tomato and rice plants were grown in MS medium for two days and log-phase B. 
thailandensis was inoculated into the spent-medium of these plants. Among the plants 
that were tested, it was found that B. thailandensis can survive and grow in the spent-
medium of Arabidopsis and tomato after one day of incubation (Figure 2.1). However, 
growth of the bacteria was not observed when it was inoculated into the spent-




                         
 
Figure 2.1. Growth of B. thailandenesis in the spent-medium of various plants. 
 
The result in this experiment demonstrated that the compound involved in 
mediating growth inhibition could be a phytoanticipin that is constitutively secreted 
by the plants, since bacteria do not have to be co-inoculated with the plant before 
inhibition can be observed. This is ideal for the isolation of the compound since 
metabolites that are derived from the bacteria can be excluded from the purification 
procedure. However, it does not rule out the fact that co-inoculating the plant with the 
bacteria can increase the production yield of this compound, since it had been 
demonstrated that the production of anti-microbial metabolites in Arabidopsis can be 
significantly increased when challenged with a non-host pathogen (Bais et al, 2005).  
It was surprising to discover that when fresh Murashige and Skoog (MS) 
medium was inoculated with B. thailandensis, the medium also remained clear after 
one day of incubation. This observation suggested that either the growth of B. 
thailandensis observed in the spent-medium of Arabidopsis and tomato was activated 
by the secondary metabolites secreted by these plants, or the components present in 
the MS medium that are responsible for growth inhibition of B. thailandensis, were 
broken down by these plants. To exclude these possibilities, the effect of growth 
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inhibition would be performed by comparison between MS medium and the spent-
medium of rice plants in all subsequent assays. 
In order to attribute the lack of bacterial growth observed in the spent-medium 
of rice plant to an anti-microbial compound, a more sensitive bioassay had to be 
developed. Hence, a plate-count assay was used to detect the number of colony 
forming units (CFU) remaining in the spent-medium after six hours of incubation. 
Using an inoculum of 1 × 10
6
 CFU/ml and incubation at 25C, we detected a 10-fold 
difference in the number of CFU remaining in spent-medium as compared to the MS 
medium control (Figure 2.2). It is also interesting to note that the effect of this 
inhibition appears to be bacterostatic, since the number of CFU remaining in the 




                                            
 
Figure 2.2. Plate-count assay to detect the inhibition of B. thailandenesis in the spent-
medium of rice plants. (1 × 10
6
 CFU/ml) Inoculum of 1 × 10
6
 CFU/ml and incubation 
at 25C. (1 × 104 CFU/ml) Inoculum of 1 × 104 CFU/ml and incubation at 37C. 
(Control) MS medium. (Rice) Spent-medium of rice plants. 
 
In further attempts to improve the effect of the inhibition, we discovered that 
lower inoculums (1 × 10
4
 CFU/ml) and higher incubation temperatures (37C) 
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enhanced growth inhibition by 1000-fold (Figure 2.2). In addition, a lower inoculum 
resulted in a switch from bacterostatic to bactericidal inhibition, as demonstrated by 
the reduction in the number of CFU remaining in the spent-medium after incubation. 
This switch is most likely attributed to a low concentration of inhibitor that is present 
in the sample, which is insufficient to elicit a bactericidal effect when a much higher 
inoculum was used. Since the main concern at this stage of the project is the ability 
for us to track the inhibitory compound during purification, an inoculum of 1 × 10
4
 
CFU/ml B. thailandenesis was used in all the subsequent growth inhibition assays. 
In summary, despite the fact that B. thailandenesis is unable to grow well in 
MS medium, a plate-count assay was developed that enabled us to detect the 
inhibition of growth of B. thailandenesis in the spent-medium of rice plants. This 
bioassay will be utilized for subsequent studies to track the inhibitory compound(s) 
during various stages of the purification process. 
 
2.3.2.  Possible mechanism of action of the inhibitory compound 
To determine the effectiveness of this inhibitor in targeting other types of 
bacteria, four additional microorganisms were also tested using the plant-count assay. 
The bacteria that were chosen are clinically relevant, many of which are capable of 
causing opportunistic infections and have been proven to be difficult to treat with 
drugs that are currently available. The assay revealed that the growths of other 
bacteria were also inhibited in the rice spent-medium, which include A. baumannii, E. 
coli and P. aeruginosa (Figure 2.3). S. aureus is the only bacterium that does not 
display any growth inhibition. Interestingly, S. aureus was also the only Gram-
positive bacterium that was tested, suggesting that the compound might be a broad-




      
 
Figure 2.3. Plate-count assay to detect the growth inhibition of various bacteria in the 
spent-medium of rice plants. (From left) Burkholderia thailandensis, Acinetobacter 
baumannii, Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus. 
(Control) MS medium. (Rice) Spent-medium of rice plants. 
 
To provide additional insights on the identity of the inhibitor, the crude rice 
spent-medium was subjected to hydrolysis with either hydrochloric acid or sodium 
hydroxide. Since the sample would be too acidic or basic to support the growth of the 
bacteria after treatment, the sample was first neutralized with base or acid, 
respectively, prior to testing using the plate-count assay. As a control, sodium 
chloride was also added to a sample to account for the increased amount of sodium 
chloride present in the sample after neutralization. Surprisingly, it was discovered that 
the addition of sodium chloride to the rice spent-medium can abolish the growth 
inhibitory effect of the medium. More specifically, it was discovered that the loss of 
inhibition was correlated with an increasing amount of sodium chloride present in the 




                
 
Figure 2.4. Plate-count assay to detect the growth inhibition of B. thailandenesis in 
the spent-medium of rice plants with increasing sodium chloride concentration. 
(From left) 0 mM NaCl, 0.5mM NaCl, 5mM NaCl, 50mM NaCl. (Control) MS 
medium. (Rice) Spent-medium of rice plants. 
 
The observation that the addition of sodium chloride could abolish the effect 
of the growth inhibition was interesting because it provided us with insights on the 
mechanism of action of this inhibitory compound. It is well-established that bacteria 
utilize a large family of sodium/solute symporters to facilitate the uptake of nutrients 
under limiting conditions (Jung, 2001). These transporters generally make use of the 
sodium gradient generated by the sodium/proton antiporters to drive the active 
transport of solutes into the cell (Figure 2.5). Various nutrients including proline, 
galactose and glutamate are transported through these sodium/solute symporters (Jung 
et al, 2012; Watanabe et al, 2010; Raunser et al, 2006). 
Under an environment with low pH (e.g. pH of MS medium is 5.8), 
acquisition of some of the essential nutrients by the bacteria is strictly dependent on 
the functioning of the sodium/proton antiporters and sodium/solute symporters. Given 
the nature of the inhibition, it is plausible that the inhibitor is acting on the 
sodium/proton antiporters and is preventing the formation of the sodium gradient. By 
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adding sodium chloride exogenously to the sample, the sodium/solute symporters are 
able to regain their function without the need of the sodium/proton antiporters to 
generate the sodium gradient. This argument is further supported by the fact that the 
concentration of sodium in MS medium is very low (about 100 M), and thus the 
formation of the sodium gradient is strictly dependent on the functioning of the 
sodium/proton antiporters. Taken together, although we were unable to determine the 
stability of the inhibitor towards acid/base hydrolysis, the results suggested that the 
inhibitor could function by blocking a class of sodium/proton antiporters that are 




Figure 2.5. Solute transport in bacteria. Sodium/proton antiporters utilize the high 
concentration of extracellular protons to transport sodium ions out of the cell. The 
sodium gradient that is generated facilitates the transport of solutes (nutrients) into the 
cell via the sodium/solute symporters. 
 
2.3.3.  Isolation and purification of the inhibitory compound 
In an effort to purify the inhibitory compound from other components present 
in the crude mixture, the sample was filtered through a 3 kDa centrifugal filter unit. 
Both the filtrate and retentate were tested for activity and it was found that inhibition 
 40 
 
can only be detected in the filtrate but not the retentate (Figure 2.6). This suggested 
that the inhibitory compound is smaller than 3 kDa in size and filtration can be used to 
facilitate the removal of unwanted larger macromolecules that are present in the 
sample. 
 
                           
 
Figure 2.6. Plate-count assay to detect the growth inhibition of B. thailandenesis in 
the spent-medium of rice plants after separation through a 3 kDa centrigual filter unit. 
(Crude) Crude sample before filtration. (Filtrate) Filtrate collected from the device 
after filtration. (Retentate) Reconstituted sample that was retained in the filter unit. 
(Control) MS medium. (Rice) Spent-medium of rice plants. 
 
To isolate the inhibitory compound for further characterization, organic 
extraction was attempted. The main consideration involved in the choice of the 
solvents included its immiscibility with water and the use of solvents with different 
polarity. This is a logical attempt since we currently do not have any information on 
the chemical property of the active compound. The solvents that were used (with 
increasing polarity) include hexane, diethyl ether, chloroform and ethyl acetate, 
respectively. After extraction, both the aqueous and organic phases were assayed for 
growth inhibition. From the results, we observed that inhibition could only be 
detected in the aqueous phases but not the organic phases of the extraction (Figure 
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2.7). This indicated that the compound might be hydrophilic in nature and thus cannot 




Figure 2.7. Plate-count assay to detect the growth inhibition of B. thailandenesis in 
the spent-medium of rice plants after extraction with various organic solvents. Both 
the aqueous and organic phases of the extraction were collected for analysis (From 
left) Hexane, chloroform, ethyl acetate and diethyl ether. (Control) MS medium. 
(Rice) Spent-medium of rice plants. 
 
To overcome the limitation posed by liquid-liquid phase extraction with 
organic solvents, we attempted to extract the inhibitor using solid-phase cartridges. 
Solid-phase cartridges that have better recovery, capacity, reproducibility and 
selectivity over polar, hydrophilic analytes (compared to traditional C18 solid-phase 
cartridges) were selected. The cartridges that were used included the hydrophilic-
lipophilic balance (HLB), mixed-mode cation exchange (MCX) and mixed-mode 
anion exchange (MAX) cartridges, which could theoretically be used to isolate polar, 
basic or acidic compounds, respectively. The chemical identities of the sorbent for 
these cartridges are summarized in Figure 2.8. Another unique feature of the sorbent 
is that it comprise of both hydrophilic and lipophilic components, which could 
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Figure 2.8. Chemical nature of the sorbents in solid-phase extraction cartridges. HLB 
cartridges can be used to extract polar compounds, MCX cartridges can be used for 
basic compounds while MAX cartridges can be used for acidic compounds. 
 
After the samples were extracted using the solid-phase cartridges, the 
flowthroughs and eluents were assayed for growth inhibition (Figure 2.9). It is 
reasonable to conclude that the HLB cartridge cannot be used for the extraction of the 
inhibitor, as growth inhibition was fully retained in the flowthrough but could not be 
detected in the eluent. On the other hand, it was surprising to discover that the 
flowthrough of both the control and the sample from the MCX cartridges were 
inhibitory towards the growth of B. thailandensis. One possible reason is that some 
components present in the MS medium that are essential for the growth of B. 
thailandensis was removed during the extraction. Given the chemical nature of the 
sorbent used in the MCX cartridges, it is likely that some of the salts present in the 
MS medium were retained in the cartridges. Another possible explanation is that there 
could be some residual compounds present in the MCX cartridges that are inhibitory 
 43 
 
towards the growth of bacteria. Nevertheless, since no inhibition was detected in the 
eluent of the MCX extraction, we can conclude that the MCX cartridges cannot be 
used for the isolation of the inhibitory compound. 
 
      
 
Figure 2.9. Plate-count assay to detect the growth inhibition of B. thailandenesis in 
the spent-medium of rice plants after extraction with solid-phase cartridges. Both the 
flowthrough and eluent were collected for analysis. (From left) Extraction with HLB, 
MCX and MAX cartridges. (Control) MS medium. (Rice) Spent-medium of rice 
plants. 
 
The results obtained from the extraction of the sample using MAX cartridges 
were equally puzzling. A lack of growth inhibition was detected in both the 
flowthrough and eluent. Since the cartridge was not washed with any solvent prior to 
elution, we can exclude the possibility that the inhibitor was accidentally removed 
through the washing of the cartridge. However, as methanol and formic acid were 
both present in the elution solvent used for the MAX cartridges, we hypothesized that 
the loss of growth inhibition could be attributed to the reactivity of the methanol or 
formic acid towards the inhibitor. Surprisingly, it was discovered that treatment of the 
samples with either methanol, ethanol or formic acid can abolish the effect of the 
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growth inhibition (Figure 2.10). With this unexpected finding, it was concluded that 
the MAX cartridges cannot be used for the isolation of the inhibitor, since the solvent 
used for the elution will react with the inhibitor. 
 
      
 
Figure 2.10. Plate-count assay to detect the growth inhibition of B. thailandenesis in 
the spent-medium of rice plants after treatment with organic solvents and formic acid. 
(From left) Treatment with absolute methanol, absolute ethanol and 2% formic acid. 
(Control) MS medium. (Rice) Spent-medium of rice plants. 
 
In conclusion, size-based separation of the crude rice spent-medium through a 
membrane has allowed us to determine that the size of the inhibitor is smaller than 3 
kDa. However, due to the hydrophilicity of the compound, we are unable to isolate the 
compound by extraction with organic solvents. In addition, the reactivity of the 
elution solvent towards the inhibitor also prevented further isolation of the inhibitor 
using solid-phase cartridges. 
 
2.3.4.  Mass spectrometry profiling of the root exudates of rice plants 
Since we were unable to isolate the compound for further characterization, 
metabolic profiling was used to provide additional information of the inhibitor. In 
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such approach, either mass spectrometry or high resolution nuclear magnetic 
resonance (NMR) can be used to determine the chemical properties of the metabolites 
present in a complex mixture. These methods had been used successfully for the 
characterization of metabolites from various plants, both qualitatively and 
quantitatively (Agneta et al, 2012; Chatterjee et al, 2010; Budantsev et al, 2010). 
Given the high sensitivity of mass spectrometry, it was used in this experiment 
to compare the profile of metabolites present in the MS medium and the spent-
medium of rice plants, via differential metabolite profiling (appendix Figure 1). The 
comparison suggested a number of compounds that was present in the spent-medium 
of rice plants but absent in the MS medium control. Since earlier experiments gave us 
some clues that the inhibitor is less than 3000 Da and hydrophilic in nature (see 
section 2.3.3), additional criteria were imposed during the analysis of the mass 
spectrometry profile of both samples. This includes setting the threshold of the m/z 
ratio to be less than 3000, and excluding compounds that were eluted after five 
minutes of the reversed-phase liquid chromatography separation. With that, we were 
able to narrow down the potential inhibitor to two unique compounds. The first 
compound had a mass of 242.05122 Da and its relative abundance was four-fold 
higher in the spent-medium of rice plants when compared to the control (Figure 2.11). 
The second compound had a mass of 404.10387 Da and could only be detected in the 
spent-medium. With the exact masses of both compounds, their elemental 
composition was predicted to be C6H12O9N and C12H22O14N, respectively. The 
presence of nitrogen atom in the elemental composition of these compounds 
suggested that the inhibitor could be a plant-derived alkaloid. 
Although the mass spectrometry profiling of the root exudates of rice plants 
provided us with clues on the possible masses and elemental compositions of the 
 46 
 
inhibitor, the chemical structures of these compounds are currently still unknown. 
This is because we were unable to purify sufficient quantity of the compounds for 
NMR analysis. To overcome this limitation, high resolution NMR metabolite 
profiling can be used in the future to facilitate the identification of these inhibitory 
compounds. Such approach relies on the simultaneous comparison of chemical shifts 
contributed by all the compounds present in the complex mixture. Once the structures 
of these compounds were deduced, they can be produced in larger quantities by 
chemical synthesis and tested for their efficacy in the killing of various Gram-
negative bacteria pathogens. 
 
 
Figure 2.11. Relative abundance of unique, hydrophilic molecules detected in the 
spent-medium of rice plants. The intensity of each signal was listed in cps (counts per 





CHAPTER 3: COMBINATORIAL BIOSYNTHESIS OF NOVEL 
POLYKETIDES USING TYPE III POLYKETIDE SYNTHASES 
 
3.1. Introduction 
Combinatorial biosynthesis methodologies have been used extensively for the 
production of polyketides with “drug-like” properties. Just recently, a group of 
researchers demonstrated the use of precursor-directed combinatorial biosynthesis for 
the production of novel polyketides and identified a few lead compounds with anti-
angiogenic or anti-cancer properties (Kim et al, 2009; Kwon et al, 2010). To expand 
the repertoire of polyketide that can be produced by type III PKS, a combination of 
precursor-directed biosynthesis and structure-based mutagenesis were used for the 
production of novel polyketides in this study. 
In precursor-directed biosynthesis, we explored the use orthologous CoA-
ligases to catalyze the synthesis of acyl-CoA thioesters using various acids and 
Coenzyme A (CoA) as substrates. The acyl-CoA thioesters can then be used as 
precursors for the production of polyketide by type III PKSs. With the availability of 
a rice cDNA library, a CHS from rice (OsPKS) was cloned for use in this experiment. 
This enzyme was identified from a BLAST search and shares a 79% sequence identity 
with MsCHS. Hence, it is likely that this enzyme will have a similar substrate and 
product profile as MsCHS. MsCHS was previously reported to work on various 
derivatives of cinnamoyl, 3-phenylpropanoyl, phenylacetyl, benzoyl and short to 
medium-length acyl-CoA to produce a wide range compounds including chalcones, 
styrylpyrones and lactones (Jez et al, 2002). Structure-based mutagenesis was also 
used to expand on the diversity of products synthesized by OsPKS, which required the 
mutagenesis of selected residues within the active site of OsPKS. 
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Once the library of polyketides was generated, they were screened for anti-
microbial activities. A few microorganisms that were chosen for the screen include A. 
baumannii, E. faecalis, P. aeruginosa and S. aureus, which are microorganisms often 
implicated in nosocomial infection. In addition, B. thailandensis was used as a model 
for the identification of lead compounds to target B. pseudomallei, a causative agent 
of melioidosis. 
 
3.2. Materials and methods 
3.2.1.  Minimal inhibition concentration assay 
The MIC assay was performed based on the standard guidelines from the 
National Committee for Clinical Laboratory Standards (NCCLS), sixth edition. In 
short, each test compound was dissolved in DMSO (stock concentration of 100 mM) 
and serially diluted by two-fold with LB medium in a 96-well plate (Costar), starting 
with a concentration of 2 mM and a volume of 50 l LB in each well. For the test 
microorganism, a log-phase culture was diluted to a concentration of 1 × 10
6
 CFU/ml 
and 50 l of the diluted culture was mixed with the diluted test compounds. The 
culture was then incubated at 37C for 18 h. The MIC value is the lowest 
concentration of compound that completely inhibits the growth of the bacteria. 
 
3.2.2.  Cloning, expression and purification of OsPKS, RtMCS and ScCCL 
To clone OsPKS, total RNA was first extracted from one-month-old rice 
plants of the Indica variant (a kind gift from Dr Yin Zhong Chao, Temasek Life 
Sciences Laboratory), using the RNeasy Plant Mini Kit (Qiagen). The cDNA library 
was then constructed from the total RNA using the SuperScript III First-Strand 
Synthesis System Kit (Invitrogen). OsPKS (GI: 115485731) was amplified using 
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Platinum Pfx DNA polymerase (Invitrogen) with 1 ng of cDNA template and primers: 
5’-GAGAGACATATGGCAGCGGCGGTGACGGTG-3’ and 5’-CTCTCTGGATC-
CTCAGGCGGCGGCGCCGGCGGTG-3’. The amplified gene was cloned into a 
modified pET-15b vector (Novagen) and transformed into E. coli strain Rosetta 
2(DE3) for protein expression. 
RtMCS (GI: 3982573) was amplified with PCR from the genomic DNA of 
Rhizobium trifolii (ATCC 14479) using primers 5’-GAGAGACAATTGATGAGCA-
ACCATCTTTTCGAC-3’ and 5’-CTCTCTAGATCTTTACGTCCTGGTATAAAG-
ATC-3’. The gene was cloned into the modified pET-15b vector and transformed into 
E. coli strain BL21(DE3) for expression. ScCCL (from Streptomyces coelicolor) was 
previously cloned in the lab and maintained on the modified pET-15b vector. 
Expression of ScCCL was performed using Rosetta 2(DE3).  
To express the enzymes, the expression hosts harboring the genes were grown 
in LB medium at 25C, supplemented with either 100 g/ml ampicillin (for strain 
BL21(DE3)) or 100 g/ml ampicillin and 34 g/ml chloramphenicol (for strain 
Rosetta 2(DE3)). When the cells reached an OD600nm of 0.6, 0.1 mM of isopropyl D-
thiogalactopyranoside (IPTG) was added for the induction of protein expression for 
24 h. The cells were then harvested by centrifugation and stored at -20C. 
To purify these enzymes, the cell pellets were resuspended in a binding buffer 
containing 20 mM Tris-HCl, pH 7.9, 0.5 M NaCl and 5 mM imidazole. The cells were 
then lysed by sonication and the cell lysate was clarified by centrifugation at 15,000 
rpm for 45 min. The clarified lysate was passed through a column containing 
chelating Sepharose resin (GE Healthcare) that was previously charged with Ni
2+
. The 
column was washed once with 5 column volume (CV) of binding buffer followed by 
5 CV of wash buffer containing 20 mM Tris-HCl, pH 7.9, 0.5 M NaCl and 154 mM 
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imidazole. The enzymes were then eluted using 4 CV of elution buffer containing 20 
mM Tris-HCl, pH 7.9, 0.5 M NaCl and 100 mM L-histidine. Fractions containing the 
recombinant proteins were pulled together and dialyzed against a storage buffer 
containing 20 mM Tris-HCl, pH 8.0 and 100 mM NaCl. The enzymes were 
concentrated to about 10-20 mg/ml using 10 kDa Amicon centrifugal filter units 
(Millipore) and stored in aliquots at -80C. 
 
3.2.3.  In vitro combinatorial biosynthesis and HPLC analysis 
The reaction for ScCCL was carried out in a 100 l volume, containing 100 
mM Tris, pH 8.0, 2 mM ATP, 2 mM CoA, 2 mM MgCl2, 2 mM p-coumaric acid (or 
other starter acids that ScCCL can work with) and 500 g/ml ScCCL. The reaction for 
RtMCS was similar with the exception that p-coumaric acid and ScCCL was replaced 
with malonic acid and RtMCS. Both the reactions were incubated at 25C for 24 h. 
For the reaction of OsPKS, components used for the ScCCL reaction were mixed in a 
total volume of 50 l and incubated at 25C for 24 h. After that, the reaction was 
topped up to 100 l with 100 mM Tris, pH 8.0, 5 mM ATP, 1 mM CoA, 5 mM MgCl2, 
5 mM malonic acid, 500 g/ml RtMCS and 500 g/ml OsPKS. The reaction mixture 
was then incubated at 25C for another 24 h. Enzymes were removed by 
centrifugation through a 10 kDa Amicon ultra centrifugal filter unit (Millipore). 
For HPLC analysis, the Atlantis Prep C18 reverse-phase column (Waters) was 
first equilibrated with 1% acetonitrile/99% ammonium acetate, pH 6.5 at a flow rate 
of 1 ml/min for 20 min. 10 l of sample was then loaded onto the column and the 
flow rate was maintained at 1 ml/min for 4 min. For the next 20 min, the 
concentration of the buffer was changed to 70% acetonitrile/30% ammonium acetate 
under a linear gradient and maintain for another 4 min. The eluted compounds were 
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detected by measuring the UV absorbance at 230 nm. Mass spectrometry and NMR 
analysis were carried out by the Mass Spectrometry laboratory and Nuclear Magnetic 
Resonance Laboratory (Department of Chemistry, NUS). 
 
3.2.4.  Construction and deconvolution of the random mutants of OsPKS 
To construct the libraries of site-specific random mutants of OsPKS (S136X, 
T197X, T200X, G259X, F218X, F268X and S341X), the primers were modified to 
contain a “NNS” codon targeted towards the site of mutagenesis. The primers were 
then used for site-directed mutagenesis with the QuikChange kit (Stratagene). 
Expression and purification of each of the mutant libraries were carried out as 
described above. 
Deconvolution of the site-specific random library of OsPKS was carried out 
by picking 16 random clones and grouping them into four sets, with each set 
containing four clones. The recombinant enzymes from each set were purified and 
assayed for activity. The set of mutants possessing the required activity was further 
deconvoluted by dividing the set into four individual clones and each enzyme was 
purified and assayed for activity. 
 
3.2.5.  In vivo combinatorial biosynthesis and HPLC analysis 
For the production of polyketide using E. coli, three CoA ligases (Nt4CL, 
ScPCL and RpBZL) that are involved in the production of starter CoA thioesters were 
subcloned into the multiple cloning site 1 (MCS1) of pRSFDuet-1 vector (Novagen). 
To produce the extender malonyl-CoA, RtMCS was subcloned into the MCS2 region 
of the same vector. This vector was then co-transformed with the vector containing 
OsPKS into E. coli strain Rosetta 2(DE3). Depending on the identity of the starter 
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acid, cells harboring the appropriate CoA ligase was used for the in vivo biosynthesis 
of polyketides (see appendix Table 1). 
To synthesize the polyketides, methods described by Katsuyama et al (2007) 
were used, with slight modification. The cells harboring the biosynthetic genes were 
first grown in LB containing 100 /ml ampicillin, 30 g/ml kanamycin and 34 g/ml 
chloramphenicol at 25C. When an OD of 0.6 was reached, 0.5 mM IPTG was added 
for protein induction for 16 h. The cells were then pelleted and resuspended in 
minimal medium containing 0.5 mM IPTG, 1 mM starter acid and 3 mM malonic acid, 
and incubated at 25C for an additional 48 h. The supernatant was acidified to pH 3.0 
with 6N HCl and extracted twice with ethyl acetate. The organic solvent was then 
removed by a vacuum concentrator and the sample was dissolved in DMSO. 
HPLC analysis was carried out as described above with minor changes. 
Column equilibration was carried out using a 10% acetonitrile/90% water mixture 
containing 0.1% trifluoroacetic acid (TFA), at a flow rate of 1 ml/min for 10 min. 10 
l of sample was loaded and the acetonitrile concentration was increased to 50% 
acetonitrile/50% water over a period of 40 min. For the next 5 min, the concentration 
was further increased to 100% acetonitrile. 
 
3.3. Results and discussion 
3.3.1.  Screening of commercially available polyketides for anti-microbial activity 
Although the anti-microbial property of polyketides have been well-
documented, it was decided to validate this property through a generic MIC screen 
using 123 commercially available organic compounds in our lab, in hope of 
identifying novel anti-microbial polyketides. These compounds include various 
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organic acids, flavonoids, glycosides and many other polyketides with diverse 
structural scaffold (A list of these compounds were shown in appendix Table 2). 
The MIC screen against the five test microorganisms yielded a total of 18 
polyketides with moderate MIC values (Table 3.1). The lowest MIC value was 
observed with datiscetin, with a value of 250 M (72 g/ml) against S. aureus. On the 
other hand, delphinidin was the only compound that inhibited the growth of P. 
aeruginosa, with a MIC value of 1000 M (340 g/ml). Among the hits, 
epigallocatechin and myricetin were found to be the most broad-spectrum targeting 
compounds, with the ability to inhibit A. baumannii, E. faecalis and S. aureus. 
Interestingly, the flavanones (eriodictyol, hesperetin and naringenin) were found to be 
inhibitors that were specific towards S. aureus, which had been reported by Tsuchiya 
et al (1996). 
It was suggested from the literature that the mechanism of action for most 
flavonoids include damage to the cytoplasmic membrane, inhibition of nucleic acid 
synthesis and inhibition of metabolic components involved in the production of 
energy (Cushnie and Lamb, 2011). However, other reports had suggested that the 
mode of flavonoid inhibition is caused by the aggregation of bacteria cells, as 
observed from the treatment of S. aureus with epicatechin gallate (Stapleton et al, 
2007). Nevertheless, this primary screening effort highlights the utility in synthesizing 








Table 3.1. MIC values of commercially available polyketides. 
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3.3.2.  Assembly of enzymes for use in combinatorial biosynthesis 
As mentioned earlier, we sought to achieve the combinatorial biosynthesis of 
novel polyketides using a putative CHS identified from rice plant (OsPKS), which is 
highly similar to the well-characterized MsCHS. This enzyme was cloned from a rice 
plant-derived cDNA library and the recombinant protein was expressed in E. coli. 
Initial expression screening revealed that the expression level of OsPKS could be 
increased when the enzyme was produced using E. coli strain Rosetta 2(DE3), as 
opposed to strain BL21(DE3). Since the codon usage of OsPKS might not be 
optimized for expression in E. coli, the Rosetta 2(DE3) strain is able to overcome this 
problem by providing an additional supply of rare tRNAs in the cells. SDS-PAGE 
analysis of the purified protein also confirmed that the mass of OsPKS is about 42 
kDa (appendix Figure 2). 
Based on the ability of MsCHS to catalyze the synthesis of naringenin from p-
coumaroyl-CoA and malonyl-CoA, it was decided to use these substrates for the 
detection of OsPKS activity. However, p-coumaroyl-CoA is not commercially 
available and compounded by the high cost of malonyl-CoA, we had to couple the 
synthesis of these CoA thioesters with two additional recombinant CoA-ligases; 
ScCCL from Streptomyces coelicolor and RtMCS from Rhizobium trifolii (Figure 
3.1). These enzymes had previously been demonstrated to catalyze the synthesis of 
CoA thioesters from its respective acid precursor (Kaneko et al, 2007; Pohl et al, 
2001). Overall, the coupled reaction required p-coumaric acid, malonic acid, ATP, 
CoA and the three different enzymes to produce naringenin, which could then be 
detected after separation by HPLC. The advantage of setting up the coupled reaction 
is that it allowed us to set up the stage for precursor-directed biosynthesis, which 





Figure 3.1. Schematic diagram for the coupled in vitro combinatorial biosynthesis of 
naringenin from p-coumaric acid and malonic acid. (ScCCL) CoA Ligase from 
Streptomyces coelicolor. (RtMCS) CoA Ligase from Rhizobium trifolii. (OsPKS) 
Chalcone synthase from Oryza sativa. 
 
Analysis of the reaction products by HPLC revealed that all the recombinant 
enzymes were catalytically active (Figure 3.2). As expected, ScCCL was found to be 
capable of catalyzing the formation of p-coumaroyl-CoA from p-coumaric acid while 
RtMCS was able to catalyze the formation of malonyl-CoA from malonic acid 
(malonic acid is not aromatic and hence cannot be detected at 230 nm wavelength). 
Two new peaks were detected when all the substrates were co-incubated with ScCCL, 
RtMCS and OsPKS, with a retention time (Rt) of about 14.1 min and 24.1 min. Using 
mass spectrometry analysis, the compound with Rt = 14.1 min was discovered to be 
acetyl-CoA. The second compound was confirmed to be naringenin when its retention 
time was compared with a standard. Detection of acetyl-CoA as a side product is most 
likely resulted from the decarboxylation of malonyl-CoA by OsPKS, which had been 
observed in MsCHS (Jez et al, 2000). The decarboxylation of malonyl-CoA is a 
crucial step of the reaction because it provides the enzyme with the highly reactive 
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acetyl-CoA carbanions that are required for the extension of the polyketide chain. 
Overall, the HPLC profile of the reaction mixture demonstrated that recombinant 




Figure 3.2. HPLC profile of the reaction products of ScCCL, RtMCS and OsPKS 
using p-coumaric acid and malonic acid. Reaction in the (A) absence or (B) presence 
of ScCCL. Reaction in the (C) absence or (D) presence of RtMCS. Reaction 
containing ScCCL and RtMCS but in the (E) absence or (F) presence of OsPKS. 
 
It is also interesting to note that although the coupling of malonyl-CoA 
synthetase with a chalcone synthase had been demonstrated to be viable for the 
production of polyketides analogues, we further demonstrated that both the starter and 
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extender substrates can be produced by coupling the reaction with more than one CoA 
ligases (Kim et al, 2009). This finding provides us with a useful toolkit for the 
diversification of polyketides analogues that we can produced through the use of 
precursor-directed combinatorial biosynthesis. 
 
3.3.3.  Precursor-directed combinatorial biosynthesis 
To facilitate precursor-directed combinatorial biosynthesis, additional CoA 
ligases (Nt4CL from Nicotiana tabacum, ScPCL from Streptomyces coelicolor and 
RpBZL from Rhodopseudomonas palustris) were also recruited for the production of 
other classes of thioesters. These thioesters can then be used as substrates for OsPKS 
to produce novel polyketides. Previous characterization of these CoA ligases (along 
with ScCCL and RtMCS) in our lab revealed that these enzymes were able to produce 
a total of 79 unique CoA thioesters from a library of 123 carboxylic acids that were 
tested (Go et al, 2012). 
As a proof of concept to determine if OsPKS is able to utilize the 79 CoA 
thioesters as substrates, OsPKS was screened using the coupled assay with ScCCL 
and RtMCS, against the 15 starter acids that ScCCL could work on. These acids are 
derivatives of compounds belonging to one of the three different chemical classes, 
namely the aliphatic acids, 3-phenylpropanoic acids and cinnamic acids. HPLC 
analysis of the coupled reaction revealed that OsPKS was highly promiscuous, with 
the ability to produce at least one product with all the substrates that were tested 
(Table 3.2). In addition, the enzyme was able to synthesize more than one product 
when ten compounds were used as substrates. As the masses of the new products were 
not determined by mass spectrometry, the exact identities of these products were not 
known. However, some of these products could be “derailment” side products 
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generated from the CHS reaction, which include polyketides with shorter chain length 
or those that are generated through a different mode of cyclization (Figure 1.6). 
 






The finding that OsPKS (and along with most other Type III polyketide 
synthases) is highly promiscuous is not surprising given the involvement of these 
enzymes in the production of secondary metabolites in plants. Some of these 
metabolites can serve as anti-microbial agents, providing the plants with protection 
against harmful microorganisms in the environment. Hence, it is likely that the 
promiscuity associated with these enzymes will allow the plants to respond promptly 
to any new threat that arise in the environment. This will provide the organism with a 
survival advantage over other members that harbor polyketide synthases of greater 
substrate/product specificity. 
 
3.3.4.  Structure-based mutagenesis of OsPKS 
Given the limited number of substrate that we can use for precursor-directed 
combinatorial biosynthesis, we decided to use structure-based mutagenesis as an 
alternative strategy to further increase the diversity of polyketides formed by OsPKS. 
In this approach, selected residues within the active site of the enzyme were targeted 
for mutagenesis to construct a library of site-specific random mutants, which would 
then be screened for their ability to produce novel polyketides. These residues 
included Ser136, Thr197, Thr200, Gly259, Phe218, Phe268 and Ser341 (numbering 
based on OsPKS), which were chosen based on their close proximity to the product-
binding pocket, as observed in the naringenin-bound structure of MsCHS (Figure 3.3). 
From the literature, it was suggested that the identity of these residues can affect the 
volume and shape of the active site cavity, which will in turn alter the type of 





Figure 3.3. Naringenin-bound crystal structure of MsCHS showing the active site 
residues. (PDB code 1CGK). (Red) Catalytic triad residues. (Green) Corresponding 
residues in OsPKS that were targeted for mutagenesis. (Purple) Naringenin. 
 
To test the effectiveness of the random mutant libraries for the production of 
novel polyketides, the recombinant mutant enzymes were purified for in vitro 
biosynthesis using the 15 starter acids that ScCCL can work on (Table 3.2). The 
HPLC analysis of these reactions revealed that most of the mutant enzymes displayed 
a different product profile when compared to wild-type OsPKS. An example was 
illustrated with the reaction that contained 3-(4-methoxyphenyl)propanoic acid and 
malonic acid as substrates. With wild-type OsPKS, the main product that was formed 
from the reaction has a retention time of 19.4 min (Figure 3.4B). However, 
recombinant enzymes from three of the mutant libraries (T197X, G259X and S341X) 










Figure 3.4. HPLC profile of the reaction products of wild-type and mutant OsPKS 
using 3-(4-methoxyphenyl)propanoic acid and malonic acid. Reaction containing 
ScCCL and RtMCS but in the (A) absence or (B) presence of OsPKS. (C) Reaction 
products of various OsPKS mutants. The new product that is produced only in the 
OsPKS mutants is marked with a red arrow. (D) Chemical structures of the products 
of OsPKS and mutants. 
 
Both the reaction products were isolated and their identities were determined 
by mass spectrometry and NMR. Interestingly, the compound synthesized 
predominantly by wild-type OsPKS was found to be a pyrone-derivative generated 
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from a lactone cyclization (C5-O  C1) of the triketide precursor (Figure 3.4D). 
Similarly, the new product formed by the OsPKS mutants was also a pyrone-
derivation but was derived from a tetraketide. This finding suggested that although 
wild-type OsPKS preferentially catalyze the synthesis of a tetraketide product when it 
is presented with its native substrate, p-coumaroyl-CoA, the use of an unnatural 
substrate such as 3-(4-methoxyphenyl)propanoyl-CoA would cause an early 
termination of the reaction, resulting in the formation of a triketide product. This 
finding also supported the hypothesis that the volume of the enzyme’s active site 
cavity can control the length of the polyketide extension, and the early reaction 
termination caused by 3-(4-methoxyphenyl)propanoyl-CoA is likely to be resulted 
from its larger molecular size as compared to p-coumaroyl-CoA (the methoxy group 
in 3-(4-methoxyphenyl) propanoyl-CoA is replaced by hydroxyl group in p-
coumaroyl-CoA). 
Since the site-specific mutant libraries of OsPKS harbor more than one type of 
mutation in each library, an attempt was made to deconvolute the exact mutant(s) 
capable of enhancing the synthesis of the tetraketide pyrone-derivative. From a 
selection of 16 random clones from the S341X library, a mutant (S341N) was 
identified (Figure 3.4C). It was surprising to learn that mutation from a serine to 
asparagine residue can caused the enzyme to favor the synthesis of a tetraketide over a 
triketide product, since the mutation would most likely cause a decrease in the volume 
of the active site cavity, due to the more bulky asparagine side chain. One possible 
explanation is that the side chain of asparagine could be involved in the stabilization 
of the growing polyketide chain.  Nevertheless, these observations suggested that they 
could be many other determinants that are involved in controlling the termination of 
the polyketide chain extension, which can only be understood after the crystal 
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structure of the S341N mutant is obtained. To achieve that, we had purified the 
catalytically inactive mutants (C167A and C167A/S341N) of OsPKS and are 
currently trying to obtain the crystal structures of these enzymes. Overall, the 
experiments with the precursor-directed biosynthesis and structure-based mutagenesis 
of OsPKS demonstrated that both combinatorial approaches can be used in 
conjunction with one another to bring about a further increase in the diversity of 
polyketides produced. 
 
3.3.5.  Screening, isolation and characterization of an anti-microbial polyketide 
To facilitate the screening and identification of polyketides with anti-microbial 
activity, in vivo combinatorial biosynthesis was used. This approach bypasses the 
need for the use of expensive cofactors such as CoA and ATP in the reaction. In 
addition, enzymes that are required for in vivo biosynthesis do not need to be purified, 
which can be tedious if the enzyme has low expression yield or when a lot of different 
enzymes are required. For the synthesis, four different CoA ligases (Nt4CL, ScPCL, 
RpBZL and RtMCS) were subcloned into a pRSFDuet-1 vector and then co-
transformed with the OsPKS-containing vector into the expression host. By feeding 
the cells harboring Nt4CL, RtMCS and OsPKS with p-coumaric acid and malonic 
acid, naringenin (Rt = 35.3 min) was produced (Figure 3.5). Comparison with a 
standard revealed that the yield of naringenin was about 0.68 mg/L culture. Although 
the yield of naringenin that we observed is much lower than that reported by 
katsuyama et al (2007) (about 80 mg/L culture), such discrepancy could be attributed 
to the difference in the catalytic efficiency of the enzymes used for the in vivo 
biosynthesis. Nevertheless, the ability to detect naringenin in the spent medium of our 
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engineered E. coli cells suggested that such approach can be utilized for the 
production of novel polyketides for use in high throughput screens. 
 
 
Figure 3.5. HPLC profile of the in vivo biosynthesis of naringenin. Ethyl acetate 
extract of cells harboring the (A) vector control or (B,C) vector containing OsPKS. (C) 
Extract spiked in with an additional 1 mM naringenin. 
 
The library of polyketides was constructed from a total of 69 starter acids 
using malonic acid as the extender, by feeding the acids separately to the cells 
harboring the expression constructs. The polyketides that were synthesized were then 
extracted using ethyl acetate and screened for their ability to inhibit the growth of five 
different bacteria: A. baumannii, B. thailandensis, E. faecalis, P. aeruginosa and S. 
aureus. From the initial screen, a number of hits were identified but were later 
confirmed to be false-positives. Nevertheless, the extract obtained from the cells fed 







Figure 3.6. Proposed biosynthesis of bisnoryangonin by OsPKS. 
 
To determine the identity of the inhibitory compound present in the cell extract, 
the mixture was separated with HPLC and individual peaks were assayed for anti-
microbial activity against S. aureus. Interestingly, although p-coumaric acid was used 
as the starter acid for biosynthesis, it was discovered that naringenin was not the 
compound that caused the growth inhibition of S. aureus. HPLC purification and mass 
spectrometry analysis of the inhibitory compound revealed that the inhibitor has a 
molecular weight of 230 (appendix Figure 3). Hence, it is likely that this compound 
is a triketide generated from the condensation of p-coumaroyl-CoA with two units of 
malonyl-CoA (Figure 3.6). Although the 
1
H NMR spectrum suggested that the 
compound may exist as various tautomeric isoforms, some of signals from the 
spectrum identified the compound as bisnoryangonin (appendix Figure 4). This 
compound is most likely generated from a C5-OC1 lactone cyclization of the 
triketide precursor. Using HPLC-purified bisnoryangonin for the MIC assay, the 
compound was found to inhibit the growth of E. faecalis and S. aureus, with a MIC 
value of 250 M (60 g/ml) and 500 M (120 g/ml), respectively. This compound 
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was unable to inhibit the growth of A. baumannii, B. thailandensis and P. aeruginosa 
at a concentration of 1 mM. These findings suggested that the compound is likely to 
be an inhibitor specific towards Gram-positive bacteria. 
Interestingly, bisnoryangonin and p-coumaroyltriacetic acid had frequently 
been identified as derailment products from the CHS-mediated synthesis of 
naringenin from p-courmaroyl-CoA and malonyl-CoA precursors (Abe and Morita, 
2010). Hence, it was not surprising to discover that bisnoryangonin was also produced 
when the cells were fed with p-coumaric acid. Moreover, since the synthesis of 
bisnoryangonin over naringenin can be favored under a reducing environment 
(Kreuzaler and Hahlbrock, 1975), in vivo biosynthesis of bisnoryangonin in E. coli 
can increase the yield of the product. This observation also highlights the utility in 
testing various reaction conditions to alter the production yield of various polyketides 
of interest. 
The anti-bacterial property of bisnoryangonin identified in this study had been 
described earlier by Benedict and Brady (1972). In their experiment, bisnoryangonin 
was identified as a metabolite from mushrooms and shown to display broad spectrum 
anti-bacterial activity against several Gram-positive bacteria (Bacillus subtilis, S. 
aureus and Mycobacterium smegmatis), with MIC values between 12 to 100 g/ml. 
Hence, our findings corroborated their earlier observations that bisnoryangonin is an 
inhibitor specific for Gram-positive bacteria, and we were able to extend the 
inhibitory effect to E. faecalis, a Gram-positive bacteria that had not been tested 
earlier by the authors. It is also interesting to note that our MIC value of 
bisnoryangonin against S. aureus was found to be higher than the value obtained by 
the authors; we determined the MIC value to be 120 g/ml while it was reported to be 
50 g/ml by the authors. This discrepancy could be attributed to the impurities that 
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were present in the HPLC-purified bisnoryangonin, including various tautomeric 
isoforms of bisnoryangonin and other co-eluted contaminants from the HPLC 
purification. A more accurate MIC value can be determined by using bisnoryangonin 
produced via chemical synthesis. 
Overall, this study had demonstrated the utility in using precursor-directed 
combinatorial for the production of polyketides, and through the coupling to a MIC 
screening platform, an anti-microbial polyketide was identified. Although the MIC 
value of this polyketide is not within the ideal range for use as an effective antibiotic, 
the study suggested that such a combinatorial approach of polyketide synthesis can be 
used to produce compounds with “drug-like” properties. Future attempt to increase 
the size and diversity of polyketides generated from combinatorial biosynthesis will 







CHAPTER 4: DEVELOPMENT OF THERAPEUTIC N-ACYL 
HOMOSERINE LACTONASES FOR THE DISRUPTION OF QUORUM 
SENSING IN GRAM-NEGATIVE BACTERIA 
 
4.1. Introduction 
Use of enzymes as drugs can be advantageous over small molecular inhibitors 
since enzymes are catalytic and highly specific. For example, lysozyme and some 
RNases have been used as anti-bacterial/anti-viral agents in various food and 
consumer products (Vellard, 2003). However, the practicality of using AHL-
lactonases as therapeutic agents for the attenuation of bacterial virulence is limited by 
the stability and reactivity of these enzymes. Ideally, the enzyme should be resistant 
towards degradation by proteases, and retain full activity under physiological 
conditions. In addition, the enzyme should be sufficiently efficient and promiscuous 
so that it can be used to target multiple pathogens that use different types of AHL 
molecules for quorum-sensing. 
Previous work in the lab led us to identify two PLLs (MCP from 
Mycobacterium avium subsp. paratuberculosis and GKL from Geobacillus 
kaustophilus) with reasonable catalytic efficiencies against medium to long-chain 
AHL, respectively. In this project, we would like to increase the catalytic efficiency 
and substrate range of these enzymes by directed evolution methodologies. Use of 
GKL as an anti-virulence therapeutic is advantageous due to the inherent 
thermostability associated with this enzyme. Once the enhanced mutants were 
obtained, they can be further characterized to provide additional information on the 
evolutionary relationship between various members of the PLL family. Structural 
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elucidation of these mutants will also enable a better understanding of the basis of rate 
enhancement in these mutants. 
As seen earlier in Table 1.3, the formation of biofilm can be mediated by 
AHL-dependent quorum-sensing in some bacterial pathogens. The biofilm is a highly 
complex structure that contains numerous extracellular polysaccharides produced by 
bacteria upon activation of their quorum-sensing system. Formation of this complex 
serves to protect the planktonic bacteria cells against chemical attack and increases 
the resistance of the bacteria towards antibiotic treatment. In A. baumannii, it had 
been demonstrated that 3-hydroxy-C12-HSL is the quorum signal required for the 
activation of biofilm development (Niu et al, 2008). To explore the feasibility of 
using AHL-lactonase in anti-virulence therapy, the engineered mutant enzymes was 
tested for their ability to disrupt A. baumannii-mediated biofilm formation. 
 
4.2. Materials and methods 
4.2.1.  Bioinformatic analysis of members of the PLL family 
The sequence alignment of various members of the PLL family was performed 
using ClustalW from GenomeNet (http://www.genome.jp/). The percentage pairwise 
sequence identity and similarity was determined using BLAST from NCBI 
(http://www.ncbi.nlm.nih.gov/). 
 
4.2.2.  Expression and purification of MCP and GKL 
MCP and GKL were previously cloned in the lab and maintained on a 
modified pET-15b vector (Novagen). To express these enzymes, the plasmids were 
transformed into E. coli strain BL21(DE3). Expression of the enzymes were carried 
by following the procedure described in Chapter 3, with the exception that the cells 
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were grown at 37C and induction was carried out for 16 h. Purification of the 
enzymes was also carried out using the Ni
2+
-charged chelating Sepharose column, as 
previously described. The eluted fractions were combined and the N-terminal His tag 
was cleaved off by digestion with thrombin (GE Healthcare), according to the 
manufacturer’s instruction. 
 
4.2.3.  Preparation of apoenzymes and metal-reconstituted enzymes 
To prepare the apoenzymes of MCP and GKL, the purified enzymes were 
dialyzed against a storage buffer (20 mM Tris-HCl, pH 8.0 and 100 mM NaCl) 
containing 10 mM ethylenediamine tetraacetic acid (EDTA). The excess EDTA was 
then removed by dialyzing the enzymes against the storage buffer. Metal-reconstituted 
enzymes were prepared by dialyzing the apoenzymes against a storage buffer 
containing 100 M of either Zn2+ or Mn2+ (depending on the metal that gives the 
highest activity). Excess metals were then removed by dialyzing the samples against 
the storage buffer. Dialyzed enzymes were concentrated to about 50 mg/ml using 10 
kDa Amicon centrifugal filter units (Millipore) and stored in aliquots at -80C. 
 
4.2.4.  Kinetic assays of lactonase and paraoxonase activites 
The substrates used in the kinetic assays were all purchased from Sigma, with 
the exception of 3-oxo-C12-HSL (Lier Chemical Co., Sichuan, China) and 3-oxo-
C10-HSL, 3-hydroxy-C10-HSL and 3-hydroxy-C12-HSL (a kind gift from Prof. Chua 
Kim Lee, National University of Singapore). The chemical structures of these 
substrates are shown in Figure 4.1. 
The lactonase activities of various enzymes were determined using a pH 
indicator assay described by Chapman and Wong (2002). Basically, each 1 ml 
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), 100 M of metal ion, 0.025 – 5 mM AHL substrate (dissolved in 
DMSO) and enzyme. The final DMSO concentration was maintained at 1% and the 
volume of the enzyme was maintained at 20 l. Paraoxonase activity was measured 
by following the method previously described by Aubert et al, (2004). Each 1 ml 
reaction contained 50 mM Tris, pH 8.0, 100 M of metal ion, 0.1 – 2.5 mM paraoxon 




, dissolved in methanol) and enzyme. Methanol 
concentration was maintained at 0.25%. For metal-dependency studies, activities of 



















Figure 4.1. Chemical structures of substrates used in the kinetic assays. 
 
All reactions were performed at 25 C for MCP (and its mutants) and 37C for 
GKL (and its mutants). The reaction for GKL requires a pre-incubation of the enzyme 
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with the metal ion at 37C for 15 min before its activity can be detected. The initial 
rates (0) of each reaction were corrected for the background rate of spontaneous 
substrate hydrolysis by measuring the rate of the reaction in the absence of enzyme. 
Kinetic parameters were determined by fitting in the initial rates and substrate 
concentration to the Michaelis-Menten equation using Enzfitter (Biosoft). 
 
4.2.5.  Random and site-specific mutagenesis of MCP and GKL 
Random mutagenesis of MCP and GKL was carried out by error-prone PCR 
with the GeneMorph II random mutagenesis kit (Stratagene). 450 ng of the plasmid 
harboring the gene was used as a template for each PCR reaction to achieve a 
mutation frequency of about 3 mutations per kb (determined by picking random 
clones for sequencing). The mutant PCR product was subcloned into pDMS1a vector 
(with ColE1 origin and Ptac promoter) and a modified pBAD33 vector (with P15A 
origin and PBAD promoter) for MCP and GKL, respectively. The mutant plasmid 
libraries were then transformed into XL1-Blue E. coli cells to construct a library with 
a size of about 8 × 10
5
 transformants. 
Construction of various site-specific mutants of GKL (A54T, E101G, D214G, 
R230C, D266N and other double/triple mutants) was carried out by using site-directed 
mutagenesis with the QuikChange kit (Stratagene). To construct the libraries of site-
specific random mutants for MCP (A265X, N266X, C267X, Y268X, F269X and 
D270X), the primers were modified to contain a “NNS” codon targeted towards the 
site of mutagenesis. The primers were then used for site-directed mutagenesis with 
QuikChange. This method routinely produces a library size of about 1 × 10
4
 
transformants. For the double site-specific random library of GKL (E101X/R230X), a 
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E101X library was first constructed and then used as a template for a second 
QuikChange reaction to randomize the R230 position. 
 
4.2.6.  Bioassay for the detection of in vivo quorum-quenching activity 
To demonstrate the quorum-quenching activity of MCP in vivo, we have 
adapted the bioluminescence-based reporter bioassay developed by Lindsay and 
Ahmer (2005). MCP was subcloned into pDMS1a vector and transformed into an 
sdiA E. coli strain (JLD271) containing the pAL103 reporter plasmid (Figure 4.4). 
The cells were then streaked onto LB plates containing 100 g/ml ampicillin, 20 
g/ml tetracycline, 25 g/ml chloramphenicol, 0.1 mM IPTG and 100 nM of 3-oxo-
C6-HSL or 3-oxo-C8-HSL. The plates were incubated overnight at 37C and 
detection of the bioluminescence was carried out using the LAS-1000 luminescent 
image analysis system (Fujifilm). Screening of MCP mutant libraries was carried out 
as described above, in the presence of 3-oxo-C8-HSL. 
 
4.2.7.  Construction of a modified biosensor for the directed evolution of GKL 
For the modification of the JLD271 E. coli strain, the LuxR-LuxCDABE 
cassette was amplified from pAL103 and subcloned into a pUC18R6K-mini-Tn7T-
Gm
R
 plasmid (Choi et al, 2005). The cassette was then integrated into the genomic 
DNA of JLD271 by co-transformation of the plasmid with pTNS2 (a plasmid that 
encodes for the transposase required for the transposition). GKL was subcloned into a 
modified pBAD33 vector and then transformed into the modified JLD271 E. coli 
strain. The cells were then streaked onto LB plates containing 25 g/ml 
chloramphenicol, 0.002 – 0.2% L-arabinose and 1 M of 3-oxo-C6-HSL. Detection of 
bioluminescence was carried out as described above. 
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4.2.8.  Thermostability studies of MCP and GKL 
To access the time-dependent thermostability of wild-type GKL, the enzyme 
was incubated at 60C for 24, 48 and 72 h in the presence of 2.5 mM bicine and 100 
M ZnCl2 before being assayed for its activity against 0.5 mM of -nonalactone. 
To determine the temperature-dependent thermostability of the evolved 
mutants, the enzymes were incubated at 60 or 90C for 15 min in the presence of 2.5 
mM bicine and 100 M ZnCl2 (for wild-type GKL, E101G/R230C and E101N/R230I 
mutants of GKL) or MnCl2 (for N266Y mutant of MCP). The enzymes were then 
cooled and assayed for lactonase activity using 0.25 – 3 mM of 3-oxo-C8-HSL. 
 
4.2.9.  Protein structure elucidation, EPR and ICP-OES analysis of GKL 
Protein crystallization, data collection, structure determination and structural 
refinement of wild-type and mutants of GKL were all performed by Dr. Xue Bo and 
Prof. Robert Robinson (Institute of Molecular and Cell Biology). To crystallize GKL 
and mutants, 50 mg/ml of each protein were grown using the vapor diffusion method 
by using a 1:1 mixture with a precipitant solution containing 100 mM Tris, pH 7.5, 
20% PEG 4000, 100 M ZnCl2 or MnCl2, and 10% glycerol. 1 mM C4-HSL was 
added for the D266N and E101G/R230C/D266N mutants and the mixtures were 
incubated at 20 C for 2 weeks. The diffraction data were collected at the National 
Synchrotron Research Center (Hsinchu, ROC). Structure determination was carried 
out by molecular replacement using GsP (a homologous PLL from Geobacillus 
stearothermophilus (Hawwa et al, 2009)) as a model in PHASER. Refinement of the 
structure was carried out using PHENIX and manual building was done using COOT. 
All the structures were visualized using UCSF Chimera (http://www.cgl.ucsf.edu/ 
chimera/). Structural alignments were performed using the “MatchMaker” function of 
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the Chimera software. Electron Paramagnetic Resonance (EPR) studies of wild-type 
GKL and its mutants were carried out by Dr. Amgalanbaatar Baldansuren and Prof. 
Sergei Dikanov (University of Illinois at Urbana-Champaign). The inductively-
coupled plasma optical emission spectroscopy (ICP-OES) was carried out at the 
Elemental Analysis Laboratory (Department of Chemistry, NUS) 
 
4.2.10.  Quantitative biofilm-disruption assay 
Wild-type and abaI mutant of A. baumannii was a kind gift from Prof. Chua 
Kim Lee (National University of Singapore). Quantification of biofilm formed by A. 
baumannii was carried out using the crystal violet staining method described by 
Taweechaisupapong et al (2005), with slight modifications. For this assay, LB 
without NaCl was used throughout the experiment due to the observation that high 
salt concentration can reduce the amount of biofilm formed by A. baumannii (Pour et 
al, 2011). An overnight culture of A. baumannii was diluted to an OD600nm of 0.8 and 
aliquot into a 96-well plate (Costar), with 100 l in each well. The plate was 
incubated at 30C for 3 h before the supernatant was removed and replaced with fresh 
medium. The plate was then incubated for an additional 21 h at 30C. To test the 
efficacy of biofilm disruption with AHL-lactonases, 10 l of purified enzymes (40 
mg/ml) was added to each well prior to the 3 h and 21 h incubation at 30C. Five 
replicates were used for each sample. 
To stain the biofilm, the waste culture was removed and each well was washed 
twice with 200 l of sterile, distilled water to remove the planktonic cells. The biofilm 
was then fixed with 125 l methanol for 15 min before they are stained with 1% 
crystal violet (Sigma) for 15 min. Excess crystal violet was removed by washing each 
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well with 200 l water three times. The dye was solubilized with 33% glacial acetic 
acid and absorbance was detected at 600nm with a microplate reader (BioTek). 
 
4.2.11.  Confocal laser scanning microscopy (CLSM) of biofilm 
For structural analysis of the biofilm after treatment with AHL-lactonases, the 
biofilm was grown using the methodology described above, with the exception that 
the culture was grown in a glass-bottomed 35 mm -Dish (ibidi), with a volume of 1 
ml. Addition of AHL-lactonase (40 mg/ml) was scaled up to 100 l per dish and the 
culture was grown for a total of 48 h instead of 24 h. Fresh medium and enzyme was 
added after 3 h and 24 h. 
The biofilm was stained by adding 500 l of 5 g/ml Alex Fluo 488-
conjugated wheat germ agglutinin (WGA) (Invitrogen) dissolved in Hank’s balanced 
salt solution (HBSS) to the dish and incubated at 37C for 30 min. The dish was then 
washed twice with 2 ml of HBSS and fixed with 500 l of 3.7% formaldehyde 
(dissolved in HBSS) at 37C for 30 min. After that, the dish was washed again once 
with HBSS and stored in the dark at 4C. 
Confocal microscopy was performed with the 1X81 inverted fluorescence 
microscope (Olympus). Image stacks were captured at a magnification of 63X, with a 
stack interval of 0.21 m for a total of 97 stacks. All the images were analyzed and 
processed using the FV1000 Viewer software (Olympus). Maximum biofilm 
thickness was determined by measuring the largest stack interval between the base 






4.3. Results and discussion 
4.3.1.  Sequence alignment of members of the PLL family 
The sequence alignment of selected members (including MCP and GKL) of 
the PLL family revealed that all the important active site residues involved in the 
coordination of the bimetallic center are fully conserved (Figure 4.2). This includes 
the four His at the end of the first, fifth and sixth -strands, respectively, a 
carboxylated Lys at the end of the fourth -strand, and an Asp at the end of the eight 
-strand. In addition, residues located within the predicted -strands are also 
conserved, suggesting that these enzymes are prototypical members of the 
amidohydrolase superfamily bearing the (/)8-barrel fold. Although the structural 
features and catalytic mechanisms of these enzymes are expected to be the same as 
other members of the PLLs, sequence analysis alone cannot be used for the functional 
assignment of these enzymes. 
As expected, PTE has the lowest sequence identity (28 – 35%) with other 
members of the PLLs and possesses a longer N-terminal sequence with an additional 
loop at the end of the 7-strand (Table 4.1). Apparently, these differences are 






) detected in 
PTE but not in other PLLs (Roodveldt and Tawfik, 2005). 
 Despite having high sequence identity, the property and reactivity of some 
members of the PLLs can be remarkably different. PPH was previously described by 
Afriat et al (2006) to exhibit a low expression yield (less than 1 mg/L culture) and 
broad spectrum AHL-lactonase activity. However, in our attempt to characterize MCP, 
which has a 92% sequence identity with PPH, we discovered that its expression yield 
is much higher (30 mg/L culture) but display an AHL-lactonase activity that is only 





Figure 4.2. Sequence alignment of various members of the PLL family. PTE from 
Pseudomonas diminuta, AhlA from Rhodococcus erythropolis, PPH from 
Mycobacterium tuberculosis, SsoPox from Sulfolobus sulfataricus, Dr0930 from 
Deinococcus radiodurans, MCP from Mycobacterium avium subsp. paratuberculosis, 
GKL from Geobacillus kaustropilus and GsP from Geobacillus stearothermophilus. 
Residues involved in the interaction of the bimetallic center are highlighted in red. 





Table 4.1. Percentage pairwise sequence identity and similarity of PTE, AhlA, PPH, 








Another notable example comes from recent characterization of Dr0930 by 
Xiang et al (2009), where they reported that this enzyme exhibited a unique type of 
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lactonase activity; it was unable to hydrolyze AHLs despite having a high activity 
against - and -lactones. Given the high sequence identity of Dr0930 (29 – 60%) 
with other PLLs capable of hydrolyzing AHLs, it leaves one to wonder how do the 
differences in the sequence of Dr0930 from other PLLs translate to its unique 
substrate specificity. These examples highlight the utility of using members of the 
PLL family for the development of enzymes for therapeutic application, since 
minimal changes to critical residues alone are often sufficient to alter the activity, 
specificity or even solubility of these enzymes. 
 
4.3.2.  Directed evolution of MCP for increased AHL-lactonase activity 
Previous work on the characterization of MCP revealed that it is a soluble 




 for its activity against medium to long-
chain AHLs (Table 4.2 and Table 4.6). To develop this enzyme into a more effective 
anti-virulence therapeutic, the catalytic activity and substrate range of this enzyme 
have to be improved. This can be achieved by constructing a library of random 
mutants of MCP by error-prone PCR and screening for mutants with enhanced 
quorum-quenching activity. Error-prone PCR was used for the mutagenesis of MCP 
since the contributing factors that can modulate the activity of MCP remain unknown. 
The constructed mutant library would then be transformed into a biosensor for the 
identification of enhanced mutants. The biosensor that was used is able to detect 
exogenous AHL molecules added into the growth medium and will exhibit a 
bioluminescent signal upon activation of its reporter gene cassette (Figure 4.3). 
Hence, the presence of a mutant MCP with enhanced quorum-quenching activity will 





Figure 4.3. Molecular circuit used to detect in vivo quorum-quenching activity. 
Addition of exogenous AHLs leads to the activation of the reporter gene cassette 
(LuxCDABE) and results in bioluminescence. Expression of an AHL-lactonase will 
hydrolyze the AHLs, leading to the quenching of the bioluminescent signal. (Top) 
Biosensor used for the screening of MCP mutants. MCP is expressed from a high 
copy plasmid with a Ptac promoter while the reporter cassette is located on a low copy 
plasmid. (Bottom) Biosensor used for the screening of GKL mutants. GKL is 
expressed from a low copy plasmid with a PBAD promoter while the reporter cassette 
is integrated into the genome. 
 
From the screen, we managed to identify a MCP mutant that was able to 
quench the bioluminescent signal better than wild-type MCP, in the presence of 
substrates 3-oxo-C6-HSL or 3-oxo-C8-HSL, respectively (Figure 4.4). Sequence 
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analysis of this mutant revealed that it contained a single mutation, N266Y, located at 
the end of the eighth -strand of MCP (Figure 4.2). After this mutant enzyme was 
expressed and purified (appendix Figure 2), measurement of its kinetic parameters 
revealed that the enzyme exhibited increased catalytic efficiencies (between 4- to 32-
fold) against numerous AHLs and paraoxon (Table 4.2). It is interesting to note that 
although the screen was performed in the presence of 3-oxo-C8-HSL, rate 
enhancement was also detected against paraoxon, corroborating the hypothesis that 
the paraoxonase activity is a promiscuous activity that results from the lactonase 




Figure 4.4. Comparison of quorum-quenching by wild-type and mutant MCP. 
Biosensor transformed with vector control, wild-type MCP and the N266Y mutant. 
(Left) Plate containing 100 nM 3-oxo-C6-HSL. (Right) Plate containing 100nM 3-
oxo-C8-HSL. 
 
With a limited library size generated by random mutagenesis, it is impossible 
to cover the possible sequence-function space in the mutant library of MCP. The 
observation that the N266Y mutation in MCP is located at the end of the eighth -
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strand suggested the importance of the -loops in the control of substrate preference 
for (/)8-barrel enzymes (Seibert and Raushel, 2005). Hence, we decided to 
construct six different libraries of site-specific randomly mutagenized library (A265X, 
N266X, C267X, Y268X, F269X and D270X) targeted towards residues at the end of 
the eighth -strand to screen for additional mutants of MCP with enhanced quorum-
quenching activities (Figure 4.2). 
Although we are unable to identify any enhanced mutants from the A265X, 
C267X, Y268X, F269X and D270X mutant libraries, screening of the N266X library 
with the quorum-quenching bioassay allowed us to identify six additional mutants 
(N266F, N266A, N266C, N266M, N266S and N266T) with enhanced AHL-
lactonases activity (Table 4.3). Despite significant differences in the chemical 
identities of the side chain of each mutation, all the mutants possess comparable 
enhanced catalytic efficiencies against AHLs (1.2 – 9.9 × 104 M-1s-1 against 3-oxo-
C8-HSL), suggesting that there is a certain degree of catalytic plasticity at the N266 
position of the enzyme. 
A closer look at the N266 mutants revealed that the mutation resulting in 
enhanced activity can range from amino acids with small (Ala) to polar (Ser/Thr/Cys) 
to aromatic (Tyr/Phe) side chains. An inspection of the rates of the N266 mutants also 
revealed that the increase in kcat/KM values were mainly attributed to an increase in the 
kcat values while the KM values remained comparable. Hence, the rate enhancement 
observed in these mutants could be mediated by a change in the substrate binding 
geometry that facilitated catalysis. However, we were unable to obtain the crystal 
structures of ligand-bound catalytically MCP and its N266Y mutant, and hence, we 








Incidentally, the N266 position in MCP is replaced by a serine and cysteine 
residue in AhlA and PPH, respectively (Figure 4.2). Given the rate enhancement 
observed in the N266C and N266S mutants of MCP, it seemed probable that the 
higher AHL-lactonase activity (0.55 – 7.2 × 105 M-1s-1 against 3-oxo-C8-HSL) 
observed in these orthologous enzymes could be partially mediated by these 
mutations (Afriat et al, 2006). However, since the activities of the N266C and N266S 
mutants were still lower than the activities reported for AhlA and PPH, it is likely that 
 86 
 
some additional unknown mutations are also essential for mediating the increased 
activity of AhlA and PPH towards AHL. 
 
4.3.3.  Construction of a screening platform for the directed evolution of GKL 
The biochemical characterization of GKL had revealed that it is highly soluble 
(200 mg/L culture) and dependent on Zn
2+
 for its activity (Appendix Figure 2 and 
Table 4.6). Like MCP, GKL also displayed a substrate preference towards medium to 
long chain AHLs, albeit with lower catalytic efficiencies (Table 4.4). The high 
solubility and thermostability of GKL (see section 4.3.8) are important “traits” that 
make it a more suitable template for the development of anti-virulence therapeutics as 
compared to MCP. Hence, we would also like to improve the catalytic activity and 
substrate range of GKL through directed evolution. 
The high solubility of GKL appears to be a double-edged sword. Attempt to 
evolve the enzyme with the quorum-quenching biosensor used for the screening of 
enhanced MCP mutants was hindered by the high amount of GKL enzyme present in 
the cells. The severity of this problem is worsened by the fact that these enzymes were 
expressed using a high-copy plasmid with a strong promoter. This will result in 
increased variability of the expression level of the enzymes and increase the 
frequency of false positives, which was a major problem that was encountered during 
the screening for enhanced MCP mutants. To overcome this problem, a tightly 
regulated, tunable expression vector can be used for a more consistent expression 
level of the enzyme (Neuenschwander et al, 2007). 
As seen earlier in figure 4.3, the biosensors used for the screening of enhanced 
quorum-quenching mutants are able to detect exogenous AHLs that are added into the 
bacterial medium, leading to the activation of the reporter cassette to produce a 
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bioluminescent signal. However, if an AHL-lactonase is also expressed in the cell, it 
will hydrolyze the AHLs, thereby quenching bioluminescence. In the new biosensor 
designed for the screening of enhanced GKL mutants, the enzyme would be expressed 
from a low copy plasmid (p15A origin) using an arabinose-inducible PBAD promoter. 
In addition, any variation in the expression level of the reporter would also be reduced 
through the integration of the cassette into the genomic DNA of the biosensor using 
Tn7-mediated transposition (Choi et al, 2005). With this new biosensor, we were able 
to observe the in vivo AHL-lactonase activity of wild-type GKL against 3-oxo-C6-
HSL using a concentration of 0.2% L-arabinose (Figure 4.5). Since the 
bioluminescent signal is not quenched when the concentration of L-arabinose was 
reduced to 0.02% or lower, the newly engineered biosensor can be used as a tool for 




Figure 4.5. Quorum-quenching activity of wild-type and mutant GKLs. Biosensor 
transformed with inactive D266N mutant, wild-type GKL, E101G/R230C mutant and 
E101N/R230I mutant. (From left) Plates contain 0.2%, 0.02% or 0.002% L-arabinose 
and 1 M 3-oxo-C6-HSL. 
 
4.3.4.  Directed evolution of GKL for increased AHL-lactonase activity 
With the success gained from the screening of the randomly mutagenized 
library of MCP, the same strategy was used to create the mutant library of GKL. The 
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library of GKL mutants was transformed into the biosensor and clones with increased 
quorum-quenching activity were screened using 1 M 3-oxo-C6-HSL and 0.02% L-
arabinose. From a library of about 8 × 10
5
 transformants, a clone (designated as clone 
2109) with enhanced quorum-quenching activity was identified (Figure 4.6). 
Sequence analysis revealed that this mutant contains four different mutations, A54T, 




Figure 4.6. Deconvolution of contributing mutations from the quadruple mutant 2109. 
Plates contain 0.02% L-arabinose and 1 M 3-oxo-C6-HSL. Biosensor transformed 
with wild-type GKL, quadruple mutant 2109 and various (from left) single, double 
and triple mutants of GKL. 
 
Since random mutagenesis was used to construct the mutant library, the 
contribution of each mutation to the overall enhanced quorum-quenching activity was 
unclear. Hence, we decided to assess the importance of each mutation by constructing 
a series of single, double and triple mutants representative of mutations present in the 
quadruple mutant. It was interesting to observe that all the single mutants were unable 
to effect quorum-quenching, suggesting that the effect was mediated by more than one 
mutation (Figure 4.6). Among the double mutants, only the E101G/R230C mutant 
exhibited a comparable amount of quorum-quenching activity with the quadruple 
mutant, and all other triple mutants that contain these two mutations (E101G and 
R230C, respectively) were able to quench the bioluminescent signal as well. Taken 
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together, these results suggested that the quorum-quenching activity observed in the 
quadruple mutant could be attributed to the E101G and R230C mutations, 
respectively. 
The synergy between the E101 and R230 positions of GKL can be further 
explored through the construction of a library of site-specific random mutants targeted 
at these two positions. With the new biosensor that was developed, the expression of 
the quorum-quenching enzyme can be easily titrated by changing the concentration of 
L-arabinose. To screen for mutants with higher quorum-quenching activity than the 
E101G/R230C mutant, the concentration of L-arabinose can be decreased to 0.002%, 
where the expression of the E101G/R230C mutant is insufficient to quench the 
bioluminescence molecular circuit (Figure 4.5). 
After a random library targeted at the E101 and R230 positions of GKL was 
constructed, the library was screened for clones with increased quorum-quenching 
activity, in the presence of 0.002% L-arabinose and 1 M 3-oxo-C6-HSL, 
respectively. From the screen, a total of five unique mutants (E101K/R230P, 
E101V/R230T, E101N/R230I, E101N, R230D) were identified. The E101N/R230I 
mutant was streaked alongside the wild-type, D266N dead mutant and E101G/R230C 
mutant for ease of comparison (Figure 4.5). Purification and in vitro characterization 
of these mutants were carried out to determine the catalytic efficiencies of these 
enzymes against AHL substrates. 
 
4.3.5.  Kinetic parameters of enhanced GKL mutants 
To determine the kinetic parameters of various enhanced GKL mutants, the 
enzymes were purified and assayed for their lactonase and paraoxonase activities. 
Within expectation, the kinetic parameters of the E101G/R230C mutant were higher 
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than that of the wild-type enzyme against various AHLs, with kcat/KM values between 
1.2- to 32-fold (for C6-HSL and 3-oxo-C12-HSL, respectively) higher (Table 4.4). 
Likewise for the E101N/R230I mutant, its kcat/KM values were increased by 1.2- to 
4.0-fold over the E101G/R230C mutant (for C8-HSL and C10-HSL, respectively). 
The biggest fold improvement observed thus far was the catalytic efficiency of the 
E101N/R230I mutant against 3-oxo-C12-HSL, with a 72-fold increase over the wild-
type enzyme. Most importantly, the enhanced mutants were now able to hydrolyze 
C4-HSL, a substrate that the wild-type enzyme previously could not hydrolyze. 
Besides AHLs, the E101G/R230C and E101N/R230I mutants were also 
assayed with nonalactones and paraoxon substrates. Dr0930, a member of the PLL 
family that is highly similar (60% sequence identity) to GKL, was found to be capable 
of hydrolyzing nonalactone substrates efficiently (Xiang et al, 2009). It was 
interesting to discover that both the mutants had reduced catalytic efficiencies against 
- and -nonalactones, and no activity was detected against paraoxon. This is not 
unexpected since the screen was carried out using an AHL (3-oxo-C6-HSL) and no 
selection pressure was applied to retain activity against nonalactones and paraoxon. 
This finding supported the hypothesis that the natural evolution of new enzymatic 















It is well-accepted that the promiscuous paraoxonase activity of AHL-lactonases 
is a coincidental characteristic that stems from the overlap in the intermediates of the 
lactonase and paraoxonase reaction (Elias and Tawfik, 2012). However, the lack of 
detectable paraoxonase activity in both GKL mutants suggested that it is 
mechanistically possible to select for an enzyme with high lactonase activity but no 
paraoxonase activity. Given that the enhanced mutant of MCP (N266Y) had an 
increased catalytic efficiency against paraoxon, the mode of rate enhancement observed 
in these two groups of mutants would be distinct from each other. 
Although increased AHL-lactonase activity could be detected in the 
E101N/R230I mutant, the rest of the site-specific mutants of GKL were found to 
display lower catalytic efficiencies than the E101G/R230C mutant when tested against 
3-oxo-C6-HSL and 3-oxo-C8-HSL, respectively (Table 4.5). With the exception of the 
E101V/R230T mutant, the activities of other mutants were even lower than the wild-
type enzyme. This was surprising since these mutants were observed to have higher 
quorum-quenching activity than the E101G/R230C mutant. This discrepancy could be 
attributed to the differences between the in vivo and in vitro condition used for the 















4.3.6.  Metal requirement of wild-type and mutants of GKL 
Members of the amidohydrolase superfamily are expected to display a 
dependency on a mono- or bi-nuclear metal center for its activity. In the PLL family, 
the preference for divalent metal can range from Zn
2+
 (AhlA) to Mn
2+
 (PPH and 
Dr0930) to Co
2+
 (SsoPox and GsP) (Afriat et al, 2006; Merone et al, 2005; Xiang et al, 
2009; Hawwa et al, 2009). We have previously demonstrated that the activity of the 




 is added into the reaction while apo-
GKL is only active in the presence of Zn
2+
 (Table 4.6). With the high sequence identity 
between GsP and GKL (sequence is 99% identical), the exact reason behind the 
observed difference between the metal preference of GsP and GKL is unclear. With this 
uncertainty, we sought to determine if there is any change to the metal preference of 
each GKL mutant. Apoenzyme of each mutant was prepared by dialyzing the enzyme 
against a chelating agent (EDTA). The activities of these apoenzymes were then 










From the results of the kinetic assay, it was clear that two of the GKL mutants 
possessed an altered metal-dependency for lactonase activity. The activity of the 
E101V/R230T mutant of GKL increased in the presence of Mn
2+
, despite having higher 
activity with Zn
2+
 (Table 4.6). This was not previously seen in wild-type GKL, which 
had a strict preference for Zn
2+
. Surprisingly, the E101N mutant was found to exhibit 
activity only in the presence of Mn
2+
 but not Zn
2+
, indicating that there was a switch in 
the metal preference for this mutant. Hence, it seemed likely that the low AHL-
lactonase activity observed earlier in the E101N mutant of GKL was probably a result 
of an inappropriate condition for the enzymatic assay (Table 4.5). With this finding, we 
hope that the structures of these GKL mutants could provide us with the basis for the 
observed metal-dependency and activity of these enzymes. 
 
4.3.7.  Color and absorption spectrum of wild-type and mutants of GKL 
Like Dr0930, purified wild-type GKL was found to be purple in color at high 
concentration. However, despite the high sequence similarity between GKL and GsP, 
both enzymes were found to be differentially colored (GsP was previously reported to 
be brown in color) (Hawwa et al, 2009). Interestingly, when various GKL mutants were 
purified, their colors were also discovered to be different, ranging from yellow to brown 
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to purple in color (Figure 4.7). When the visible absorption spectrums of these 
enzymes were obtained, the maximum absorption wavelength of these enzymes was 




Figure 4.7. Color and maximum absorption wavelength of purified wild-type GKL and 
its mutants. The enzymes were dialyzed against Zn
2+
 and concentrated to 50 mg/ml. 
Their absorbance maxima were obtained by scanning through the visible light spectrum 
with a wavelength of 380 to 700 nm. 
 
The observed purple coloration in proteins is not a newly discovered 
phenomenon and had been well-studied in proteins like the purple acid phosphatase and 
uteroferrin (Pyrz et al, 1986; Davis and Averill, 1982). In these proteins (and Dr0930), 
the color is attributed to the formation of a charge-transfer complex between the 
phenolic group of a tyrosine residue and a Fe
3+
 ion (located at the site of the -cation in 
Dr0930) that are in close proximity with one another. Site-directed mutagenesis of this 
tyrosine residue and the addition of an iron-chelator into the medium during protein 
expression rendered Dr0930 colorless, confirming the importance of these two factors 
in the control of color formation in Dr0930 (Xiang et al, 2009).  
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The sequence alignment of various members of the PLL family revealed that 
this tyrosine residue is highly conserved (Tyr99 in GKL), with the exception of PTE, 
which is occupied by a tryptophan residue (Figure 4.2). In an attempt to explain the 
brown-colored protein of GsP, the authors took a closer look at the structure of GsP, 
where they discovered that the distance between the tyrosine residue and the -cation is 
increased to 3.3 Å (In Dr0930, the distance is 2.2 Å) (Hawwa et al, 2009). The authors 
proposed that the increased bond distance will decrease the strength of the charge-
transfer complex, resulting in a brown-colored protein. If their argument was true, it 
would explain the difference that was observed with the colors of various GKL mutants. 
Since the tyrosine residue is conserved in all these GKL mutants, it seems probable that 
the mutations caused a perturbation in the active site of the enzymes, resulting in a 
change in the distance between the tyrosine residue and the iron cofactor. The actual 
correlation between the color of the protein and the distance between the tyrosine 
residue and the -cation can be determined once the structures of various GKL mutants 
are obtained. Interestingly, there appears to be no correlation between the color and 
catalytic efficiency of the enzymes. 
 
4.3.8.  Thermostability of wild-type and mutants of GKL 
With the expectation that GKL is a thermostable enzyme, we sought to 
determine if the enzyme was able to retain its thermostability over prolonged heat 
treatment. The wild-type enzyme was assayed for its activity against -nonalactone 
(substrate with the highest activity on wild-type GKL) on a daily basis, where the 
enzyme was maintained at 60C for a total of three days. From the observations, it was 
discovered that GKL was able to retain its activity after the heat treatment (Table 4.7). 
In fact, the activity of GKL was found to increase gradually over the 3 days of 
 97 
 
incubation, which could be attributed to the heat-induced activation of GKL. This 
phenomenon was also observed in GsP, and was attributed to changes in the 
conformation of the enzyme upon heat treatment (Hawwa et al, 2009). 
 




To compare the tolerance level of various AHL-lactonases at elevated 
temperature, the N266Y mutant of MCP, wild-type GKL, and the E101G/R230C and 
E101N/R230I mutant of GKL were assayed for their activity against 3-oxo-C8-HSL 
after heat treatment at 60C and 90C for 15 min (Table 4.8). As expected, the activity 
of the mesophilic N266Y mutant of MCP cannot be detected when the enzyme was 
treated at 60C and 90C. However, wild-type GKL is found to be able to tolerate up to 
90C, albeit producing slightly lower kcat/KM values when the temperature of the 
treatment increases. The E101G/R230C mutant of GKL exhibited lower tolerance 
towards elevated temperature when compared to wild-type GKL; a 6-fold and 20-fold 
decrease in catalytic efficiency was observed when the enzyme was incubated at 60C 
and 90C, respectively. The enzymatic activity of the E101N/R230I mutant decrease by 
about 2.5-fold when the treatment was performed at 60C but no activity was detected 















These findings suggested that the thermostability of some enzymes could be 
easily affected through the mutation of a few critical and essential residues, and the 
selection of the E101G/R230C and E101N/R230I mutant with enhanced enzymatic 
activity was obtained through the expense of the protein’s thermostability. This poses 
great implications for the future engineering or design of enhanced catalysts as 
researchers need to ensure the maintenance of enzyme stability after catalyst 
enhancement. Nevertheless, the experiment demonstrated that although the 
thermostability of the E101G/R230C and E101N/R230I mutant was compromised, its 
ability to withstand a temperature of up to 60C (unlike the N266Y mutant of MCP) 
made it an ideal template for use in industrial applications. 
 
4.3.9.  Structural analysis of wild-type and mutants of GKL 
In an attempt to provide a structural explanation for the enhanced catalytic 
efficiencies, altered metal dependency and different coloration observed in various 
GKL mutants, we tried to obtain the crystal structures of these enzymes. Although we 
are unable to crystallize the enhanced E101N/R230I mutant, both the structures of the 
wild-type and E101G/R230C mutant of GKL were solved to a resolution of 2.1 Å and 
2.0 Å, respectively. In addition, we also managed to solve the structure of the D266N 
and E101G/R230C/D266N mutants of GKL (catalytically inactive mutants of wild-type 
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and E101G/R230C mutant, respectively) that are co-crystallized with C4-HSL, to a 
resolution of 1.6 Å and 2.2 Å, respectively. These structures will allow us to gain 
additional insights into the binding conformation of AHL in these enzymes. The 




-reconstituted E101N mutants of GKL were solved to a 
resolution of 2.6 Å and 2.1 Å respectively, and could be examined to identify any 
differences in the conformation of these enzymes when they were reconstituted with 
different metals. Lastly, a closer look at the distance between Tyr99 and the -metal ion 
in various GKL mutants would allow us to correlate the colors of the enzyme with the 
strength of the charge-transfer complex. A summary of the crystallographic data was 
shown in appendix Table 3. 
As expected, the structures of GKL and all its mutants revealed that the enzymes 
form dimers and adopt a (/)8-barrel fold, with two metal ions bound in the - and -
positions, respectively, in the enzymes’ active site. From the literature, the more buried 
-metal (occupying the M site) is coordinated to two histidine residues on the first -
strand and an aspartate residue on the eight -strand of the (/)8-barrel (Seibert and 
Raushel, 2005). On the other hand, the -metal (occupying the M site) is more exposed 
to the solvent and is coordinated to two histidines from the fifth and sixth -strand. The 
two metal ions are also bridged by a water molecule and a carbamate functional group 
that is resulted from the post-translational modification of a lysine residue on the fourth 
-strand. These features were all found to be conserved in the structures of GKL and its 
mutants, as exemplified by the structure of the D266N mutant (Figure 4.8). 
In the structure of the D266N mutant, the interatomic distance between the M 
and M site was found to be 3.6 Å, which is a typical distance observed among 
members of the amidohydrolase superfamily (Seibert and Raushel, 2005). The substrate 
binding pocket can be separated into two binding domains, with residues Phe28, Tyr30, 
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Tyr99, Arg230 and Val268, respectively, involved in the positioning of the lactone ring. 
The hydrophobic channel involved in the binding of the substrate’s aliphatic tail is 





Figure 4.8. Structure of the D266N mutant of GKL. (A) Ribbon representation of the 
overall structure of the enzyme. -Helices are colored green and -strands are colored 
magenta. (B) Active site architecture of the enzyme. The - (brown) and -cation 
(silver), six ligand residues and the bridging water molecule (red) are shown in the 
diagram. 
 
As with other AHL-lactonases of the PLL family, the mechanism of AHL-
hydrolysis by GKL most likely involves the polarization of the carbonyl oxygen of the 
lactone ring by the -cation, making the carbonyl group more electrophilic. With the 
aid of a proton extraction by Asp266, the activated hydroxide ion will undergo a 
nucleophilic attack on the carbonyl group, resulting in the formation of a tetrahedral 
intermediate. The nucleophilic hydroxide ion is positioned on the re-face of the 
substrate, which is consistent with the stereochemistry observed in other 
amidohydrolase superfamily members, such as dihydroorotase and isoapartyl 
dipeptidase (Thoden et al, 2001; Martí-Arbona et al, 2005). The reaction is completed 
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when the proton from Asp266 is transferred back to the product, resulting in a 
hydrolyzed lactone.  
 
4.3.9.1. Mechanism for enhanced catalytic efficiency in the E101G/R230C mutant 
To obtain a structural explanation for the rate enhancement observed in the 
E101G/R230C mutant of GKL, we superimposed the structures of wild-type and 
E101G/R230C mutant, and the ligand-bound structures of the D266N and 
E101G/R230C/D266N mutants. The structural alignment revealed a major difference in 
the conformation of the 3-loop in these mutants (Figure 4.9). Although visible in the 
wild-type and D266N mutant, the loop was found to be disordered in both the 
E101G/R230C and E101G/R230C/D266N mutants. In the wild-type and D266N mutant, 
the loop appears to be stabilized by interactions between the side chain of Glu101 with 
those of Thr154 and Gln110. These interactions were abolished by the E101G mutation, 
causing the loop to become more flexible. 
Detailed comparison between the ligand-bound structures revealed that there 
were obvious changes to the position and orientation of the bound substrate (Figure 
4.9). In the E101G/R230C/D266N mutant, the substrate was positioned closer to the 
binuclear center and the lactone ring was rotated by about 60. These changes were 
probably mediated by Arg230, where upon mutation to a cysteine residue abolishes the 
original interaction with the carbonyl oxygen of the lactone ring. Without the 
interaction, the substrate will be less restricted, allowing its carbonyl oxygen to move 
away from 230 position and closer to the two metal ions. 
In the E101G/R230C/D266N mutant, the position of the water molecule also 
moved towards the bimetallic center (Figure 4.9). This positioning most likely resulted 
from an indirect consequence of the E101G mutation. The flexibility of the 3-loop 
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caused by the mutation resulted in Tyr99 moving away from the -cation by about 0.9 
Å. With a decreased influence from the electron-rich hydroxyl group of Tyr99 on the -
cation, it could pull the bridging water closer to the bimetallic center. Overall, it 
resulted in a decrease in the distance between the attacking nucleophile and the M and 
M sites. All these movements also resulted in an overall change of the angle and 
orientation of the nucleophilic attack from a 22 re-face attack in the D266N mutant to 




Figure 4.9. Structures of GKL D266N and E101G/R230C/D266N mutants. (A) 
Superimposition of the D266N (green) and E101G/R230C/D266N (magenta) mutants. 
The 3-loop in D266N is highlighted in blue. (B) Close-up view of the active site. (C, 
D) Interatomic distance and facial selectivity of nucleophilic attack in the D266N and 




These observations can be used to explain the rate enhancement observed in the 
E101G/R230C mutant. It is well-accepted that an efficient catalysis of the hydrolytic 
reaction relies on the appropriate positioning of both the substrate and the attacking 
nucleophile. Ideally, the angle of the nucleophilic attack should be close to the Bürgi–
Dunitz angle of 107. The inability of wild-type GKL to hydrolyze C4-HSL could be 
attributed to the unproductive geometry presented by both the lactone ring of C4-HSL 
and the bridging water molecule, which formed a nucleophilic attack angle of 22 
(much lower than the Bürgi–Dunitz angle). In the enhanced E101G/R230C mutant, the 
angle of the nucleophilic attack is increased to 38, which is considerably closer to the 
Bürgi–Dunitz angle and hence resulting in a corresponding increase in its catalytic 
efficiency against C4-HSL. 
Although a re-face nucleophilic attack is a common feature observed in the 
catalysis of most members of the amidohydrolase superfamily, a change in the 
substrate’s facial selectivity observed in the enhanced mutant should not have any 
major impact on its catalytic efficiency. A consequence to this change is that the 
stereochemistry of the hydrolyzed product will be altered, which could be beneficial 
since it will prevent the host organism from recycling the hydrolyzed product for other 
metabolic functions. In fact, a closer look at the structure of SsoPox revealed that the 
attacking nucleophile is also positioned on the si-face of the thiolactone ring of C10-
HCL (Elias et al, 2008). This suggested that there is no dictating rule to the selection of 
the substrate’s facial orientation within members of the amidohydrolase superfamily. 
Limited by the resolution of the crystal structures, we were unable to determine 
the interatomic distances between the nucleophile and the dinuclear metal centers with 
good accuracy. With such limitation, we were unable to translate any changes in the 
reaction coordinates to a potential reduction in the energy barrier of the enhanced GKL 
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mutants. Hence, further work could be targeted towards simulation studies using 
quantum mechanical/molecular mechanical methods to examine potential changes to 
the activation free energy of the GKL mutants. Such simulation studies have been used 
extensively to provide a better understanding on the mechanism of various enzymatic 
reactions, including reactions catalyzed by the acetylcholinesterase and 
phosphotriesterase (Liu et al, 2009; Wong and Gao, 2007). 
 
4.3.9.2. Identity of metal in the M and M sites of GKL and its mutants 
Before the mechanism of the rate enhancement observed in the Mn
2+
-
reconstituted E101N mutant could be investigated, we needed to confirm the identity of 
the metal ions present at the M and M sites of these enzymes. Clues from earlier 
experiments (and from literature) indicated that the M site could be occupied by Fe
3+
 





 (to account for the metal-dependent lactonase activity). 
To corroborate our hypothesis, the identities of these metals in the wild-type 
GKL and E101G/R230C mutant were determined by performing an extended X-ray 
absorption fine structure (EXAFS) scan on the protein crystals to measure their 
characteristic fluorescence absorption edges. Analysis of the anomalous difference 
Fourier electron density maps revealed that the M sites of these enzymes were 
occupied by an iron atom while the M sites were occupied by zinc, which is contrary 
to our expectations. Based on our earlier observations during the preparation of apo-
GKL, we noted that the treatment of GKL with EDTA did not completely remove iron 
from the protein. This was deduced from the results of the ICP-OES analysis, which 
indicated that the wild-type and E101G/R230C mutant contains 0.5 and 0.8 eq of iron, 
respectively. Since iron was not added exogenously to the enzyme during dialysis, it 
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seemed logical that Fe
3+
 was buried in the more solvent occluded M site. In fact, a 
fluorescence absorption edge scan of the structure of SsoPox revealed that its M site is 
also occupied by an iron atom (Elias et al, 2008), suggesting that the identity of the 
metal at the M site is not fully conserved within the amidohydrolase superfamily. 
EPR spectroscopy was employed to determine the oxidation state of the metal 
ions and to detect the presence of spin-coupling within the bimetallic centre of GKL 
and its mutants. The spectrum scan of the Zn
2+
-reconstituted wild-type GKL, 
E101G/R230C mutant and E101N mutant revealed an intense signal with g = 4.3 
(Figure 4.10). This signal is characteristic of Fe
3+




 centers, which 
have been observed earlier in uteroferrin (David and Que, 1990). As zinc is not 
paramagnetic, we did not have direct evidence of its presence using EPR spectroscopy. 
In the Mn
2+
-reconstituted E101N mutant, the g = 4.3 signal can still be detected, 





dinuclear center (Schenk et al, 2001). More interestingly, new signals were detected in 
the g ~ 2.0 region (Figure 4.10). This area displays a hyperfine structure consisting of 




 clusters observed in 
dimanganese catalase (Pessiki et al, 1994). The exact contribution of these two forms of 
dinuclear center to the overall activity of the Mn
2+
-reconstituted E101N mutant is 





 center can be prepared by expressing the enzyme in the presence of an iron 
chelator or a medium enriched with manganese. 
In summary, observations from the EXAFS and EPR spectroscopy suggested 
that the M sites of all Zn
2+
-reconstituted GKLs are occupied by Fe
3+
 while their M 
sites are occupied by Zn
2+
. On the other hand, the Mn
2+
-reconstituted E101N mutant 








 centers that occupy the M 
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and M sites of the enzyme, respectively. High resolution EPR studies can be carried 
out in the future to obtain additional insights into the role of the binuclear metal center 




Figure 4.10. X-band EPR spectra of metal-reconstituted GKL and mutants. (A) Zn
2+
-
reconstituted GKL, (B) Zn
2+
-reconstituted E101G/R230C mutant, (C) Zn
2+
-
reconstituted E101N mutant,  and (D) Mn
2+
-reconstituted E101N mutant. 
 
4.3.9.3. Mechanism for enhanced activity in the Mn
2+
-reconstituted E101N mutant 
To provide a better understanding on the mechanism of rate enhancement 
observed in the E101N mutant reconstituted with Mn
2+





-reconstituted E101N mutants for comparison. The overall alignment 
revealed that the 3-loop of the Zn2+-reconstituted mutant is still highly disordered, 
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which we attributed earlier to the consequence of the E101G mutation (and now with 
the E101N mutation). Surprisingly, the order of the 3-loop was found to be restored in 
the Mn
2+
-reconstituted mutant. A close inspection of the alignment revealed that the 
conformation of most residues remained unchanged in both mutants, with the exception 
of Tyr99 that moved closer to the -cation in the Mn2+-containing mutant by about 2.3 
Å (Figure 4.11). With the identities of the metal elucidated, we now know that the M 
site of the Mn
2+
-reconstituted mutant is occupied by Mn
2+
. Taken together, it appears 
that the ordering of the 3-loop resulted from the tighter tethering between Tyr99 and 
Mn
2+
 that occupy the M site. 
The mechanism of enhanced catalytic activity observed in the Mn
2+
-
reconstituted E101N mutant appears to be different from the one that we had earlier 
proposed for the E101G/R230C mutant. In the E101G/R230C mutant, the mobility of 
the 3-loop translated to a weaker Tyr99-M interaction, which resulted in a more 
favorable geometry between the substrate and the nucleophile. In the Mn
2+
-containing 
E101N mutant, the strong coordination between Tyr99 and Mn
2+
 at the M site caused 
the 3-loop to remain ordered. Also, the tight Tyr99-M coordination could also 
translate to an improvement in the overall geometry posed by the substrate and the 
attacking nucleophile. However, this cannot be confirmed due to our inability to obtain 




-containing E101N/D266N mutants. 
Hence, future studies should be targeted towards a more detailed investigation of the 
correlation between the movement of the Tyr99 residue with respect to the orientation 






Figure 4.11. Structures of metal-reconstituted E101N mutants of GKL. (A) 
Superimposition of the Zn
2+
- (green) and Mn
2+
- (magenta) reconstituted E101N mutants. 
(B,C) Interatomic distance between Tyr99 and the -cation in the Zn2+- and Mn2+-
reconstituted E101N mutants, respectively. 
 
4.3.9.4. Mechanism of coloration in GKL and its mutants 
Dr0930 and GsP, members of the amidohydrolase superfamily, were previously 
characterized and found to be colored at high concentrations (Xiang et al, 2009; Hawwa 
et al, 2009). The color of these enzymes was attributed to a charge-transfer complex 
formed between a tyrosine residue and Fe
3+
. The difference between the color of 
Dr0930 and GsP was associated with the strength of this charge-transfer complex, 
which can be translated to the distance between the tyrosine residue and Fe
3+
. Hence, 
the observation that our purified GKL mutants were differentially colored led us to 
believe that the difference in coloration could be attributed to the movement of the 
tyrosine residue towards or away from the -cation. One initial surprise came from the 
EXAFS and EPR spectroscopy, which indicated that the M site of GKL and its 




, rather than Fe
3+
. This suggested that the color 
of the GKL mutants might be a result of a charged-transfer complex that formed 
between Tyr99 and Fe
3+
 located at the M site. 
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From the structural alignment of GsP, Dr0930 and various colored GKL mutants, 
we discovered that the side chain of Tyr99 could adopt a different conformation in 
these enzymes. The distance between the hydroxyl group of this tyrosine residue and 
Fe
3+
 were measured and listed in Figure 4.12. In addition, the orientation of the side 
chain of Arg230 was also found to be different in GsP and Dr0930. It is noteworthy that 
in GsP and Dr0930, the authors had assumed that the Fe
3+
 cation was located at the M 
site, based on chelation studies and its close proximity with a nearby tyrosine residue. 
However, this annotation could be wrong since we were able to demonstrate that our 
proteins were colored even if the Fe
3+
 cation is located at the more distant M site. This 





Figure 4.12. Structural alignment of the active site of GsP, Dr0930 and various GKL 
mutants. GsP (Brown, PDB code 3F4D), Dr0930 (Blue PDB code 2ZC1), Wild-type 
GKL (Purple), E101G/R230C mutant (Green), Zn
2+
-reconstituted E101N mutant 
(Orange), Mn
2+
-reconstituted E101N mutant (Pink), R230D mutant (Yellow). The 
numbering of residues is based on the sequence of GKL. The color, maximum 
absorption wavelength, distance between Tyr99 and Fe
3+
, and the identity of the - and 




Among the GKL mutants, the Mn
2+
-containing E101N mutant had the shortest 
Tyr99-Fe
3+
 distance but the purified enzyme was not purple in color. This could be 









had been detected previously in this protein using EPR spectroscopy. Within the Zn
2+
-
reconstituted enzymes, a correlation could be made between the Tyr99-Fe
3+
 distance 
and the maximum absorbance wavelength of each protein. In the R230D mutant, the 
distance between Tyr99 and Fe
3+
 was 5.2 Å, which corresponded to a dark purple-
colored protein with a high maximum absorbance wavelength (553 nm). However, if 
the distance was increased to 6.7 Å as observed in the Zn
2+
-reconstituted E101N mutant, 
it would cause the protein to become dark brown in color with a reduction in the 
maximum absorbance wavelength (535nm). Although the same correlation could be 
observed for wild-type GKL, the E101G/R230C mutant seemed to be the exception. 
This suggested that there could be some other unknown factors in the 
microenvironment of the active site that were involved in determining the color of the 
protein. 
 
4.3.10. Biofilm-disruption with quorum-quenching lactonases 
To demonstrate the feasibility of using the evolved GKL mutants as an anti-
virulence therapeutic to combat microbial infections, we wanted to test the efficacy of 
these enzymes in the disruption of biofilm formation in A. baumannii. Due to our 
inability to obtain the crystal structure of the E101N/R230I mutant of GKL (and hence 
to provide a better understanding on the mechanism of its rate enhancement), only wild-
type GKL and the E101G/R230C mutant were used in this assay. 
A. baumannii is a Gram-negative bacterium that is gaining world-wide 
recognition due to its rapid emergence as an opportunistic pathogen in nosocomial 
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infections. In hospitals, spreading of the infection has been associated with the use of 
indwelling medical devices such as catheters and implants. The situation is made worse 
by the emergence of a number A. baumannii isolates that are resistant to carbapenem, 
an antibiotic that had been used for the treatment of infection caused by A. baumannii 
(Kempf and Rolain, 2012). The persistency of A. baumannii in hospitals has been 
associated with the ability of the bacteria to form biofilms, which provide the bacteria 
with protection against harsh environmental conditions (Gaddy and Actis, 2009). In A. 
baumannii, formation of its biofilm is mediated by a typical LuxI/LuxR-type quorum-
sensing network that utilizes 3-hydroxy-C12-HSL as its quorum signal (Niu et al, 2008). 
Hence, we believe that the simplicity of its quorum-sensing pathway will make A. 
baumannii a good model organism to demonstrate the in vivo quorum-quenching 
capability of our enhanced GKL mutants. 
Although it was expected that the E101G/R230C mutant of GKL could also 
hydrolyze 3-hydroxy-C12-HSL, its actual catalytic efficiency was found to be lower 
than 3-oxo-C12-HSL (Table 4.9). A more detailed comparison of the kinetic 
parameters revealed that the catalytic rate of the wild-type and mutant GKL was highest 
against straight chain AHLs, while substitution with either an oxo- or hydroxyl-group at 
the C3 position of the AHL lowered their kcat/KM values significantly. Future 
engineering efforts should be targeted towards the rate enhancement of GKL against 
C3-modified AHLs. 
Since the biofilm of A. baumannii formed best in the presence of a low salt 
medium at 30C, this condition was used for the culturing of wild-type and abaI 
mutants of A. baumannii. As expected, deletion of the AHL-synthase (abaI) in A. 
baumannii caused a reduction in the amount of biofilm formed by the bacteria (Figure 
4.13). To determine if the biofilm of A. baumannii could be reduced in the presence of 
 112 
 
AHL-lactonases, wild-type and E101G/R230C mutant of GKL were respectively added 
to log-phase cultures of A. baumannii. The catalytically inactive D266N mutants of 
GKL were used as controls. From the Figure, both the wild-type and E101G/R230C 
mutant are capable of reducing the biomass of biofilm formed by the bacteria. Although 
the reduction appeared to be greater in the E101G/R230C mutant, the amount of 
biofilm that was formed was still considerably higher than that of the abaI mutant, 
suggesting that AHLs might still be present in the medium. 
 




CLSM was used to access the effect of the lactonase treatment to the overall 
morphology and architecture of the biofilm formed by A. baumannii. The 
E101G/R230C mutant was used since it produced a greater quorum-quenching effect 
compared to wild-type GKL. As shown in the differential image contrast (DIC) image 
in Figure 4.14, treatment with the enhanced GKL mutant caused a reduction in the 
overall mass of the biofilm formed by A. baumannii. To confirm the identity of the 
biofilm, the biofilm was stained with a fluorophore-conjugated wheat germ agglutinin, 
which is able to bind selectively to N-acetylglucosamine and N-acetylneuraminic acid 
residues within the biofilm complex. The staining revealed that there was a reduction in 
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the average thickness of the biofilm, with a decrease from 8.45  0.45 M in the 




Figure 4.13. Biofilm disruption assay by crystal violet staining. Blue columns represent 
growth of A. baumannii without the addition of AHL-lactonases. Red columns 
represent the growth of wild-type A. baumannii in the presence of different GKL 
mutants. ****, p value  0.0001. **, p value  0.01. 
 
Although it had been shown that AHL analogues can also prevent the formation 
of biofilm in A. baumannii, use of both approaches serves to complement one another 
in different situations (Stacy et al, 2012). For example, the use of AHL-degrading 
enzymes is more suitable towards the prevention of biofilm formation, which can be 
achieved by immobilizing the enzymes on the surface of catheters or implants so that 
the formation of biofilm can be prevented on these equipments. On the other hand, 




In summary, treatment of A. baumannii with our evolved GKL mutant caused a 
significant reduction in the overall biomass and thickness of the biofilm formed by the 
bacteria. Although the use of AHL-lactonases for the inhibition of quorum-sensing have 
been observed in other organisms like P. aeruginosa (Ng et al, 2011; Kiran et al, 2011), 
our work here present the first demonstration of biofilm disruption in A. baumannii 
using an AHL-lactonase. This finding highlights the potential of using AHL-lactonases 





               
               
 
Figure 4.14. CLSM images of A. baumannii biofilms after staining with Alex Fluo 
488-conjugated WGA. (Top) Cells treated with the inactive E101G/R230C/D266N 
GKL mutant. (Bottom) Cells treated with the catalytically enhanced E101G/R230C 
GKL mutant. (Left) DIC image of the biofilm. (Right) Fluorescence image of the 




CHAPTER 5: CONCLUSIONS 
Ever since the discovery of penicillin by Alexander Fleming, great progresses 
were made in the field of antibiotic development, with many of the deadly disease that 
were previously known are now curable through a simple course of antibiotic 
administration. However, towards the dawn of this century, the rapid emergence of 
antibiotic-resistant bacteria had decimated our hope of eradicating all bacterial-
mediated diseases. This problem is made worse by the long process of antibiotic 
development before they can be successfully marketed, and a lack of investments 
poured into the development of newer drugs by the private sectors. To spearhead the 
development of the next-generation antibiotics, a few novel strategies of developing an 
anti-microbial lead compound were examined. These approaches were all designed with 
the aim of identifying anti-microbial compounds with novel scaffolds, or the ability to 
suppress the rapid emergence of antibiotic resistant pathogens. 
In the first project, an attempt was made to isolate and characterize an anti-
microbial compound from the root exudates of rice plant. From the earlier observation 
that the spent-medium of rice plants was able to inhibit the growth of B. thailandensis, 
additional experiments were conducted to gain insights into the mechanism of action 
and identity of this inhibitor. It was suggested that the inhibitor might display a unique 
mode of inhibition previously not seen in other commonly used antibiotics; current 
antibiotics function through the inhibition of various important cellular processes such 
as DNA replication, transcription, translation, cell wall synthesis, cell division and 
lipid/membrane synthesis (Silver, 2011). To confirm this hypothesis, methods involved 
in altering the expression level of the putative protein target (or a library of random 
putative protein targets) can be used. This can be achieved through the use of a 
regulatable promoter to repress or activate the expression of the putative protein target, 
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such as the proposed group of membrane proteins involved in the antiport transport of 
sodium ions and protons across the membrane (DeVito et al, 2002; Li et al, 2004). If 
these membrane proteins are true targets of the inhibitor, any decrease or increase in its 
expression level will result in a corresponding change to the minimum inhibitory 
concentration (MIC) value of the inhibitor. 
The main challenges that were encountered during the isolation process were the 
low abundance of the inhibitory component and the difficulty in extracting the 
compound from the complex mixture. This is likely to be a common problem faced by 
many researchers as most high abundance natural products with anti-microbial activity 
would most likely had been discovered long ago. Hence, future attempts to isolate anti-
microbial compounds from natural products should be accompanied with major 
improvements to the methodologies used for the detection and extraction of the 
inhibitory compound. Use of plant root exudates as a starting material for the discovery 
of anti-microbial compounds should still remain attractive in the near future, given the 
large amount of biologically interesting metabolites that had been identified from root 
exudates of many plants in recent years (Bais et al, 2006). 
In Chapter three, both precursor-directed biosynthesis and structural-based 
engineering of polyketide synthases were demonstrated to be viable strategies that can 
be used for the production of novel polyketides. Although these strategies had been 
explored extensively by many independent groups, the findings in this project highlight 
the possibility of combining both approaches to further increase the diversity and 
complexity of the polyketides. As the crystal structures of other PKSs are continuously 
made available from the Protein Data Bank (PDB), more rational approaches of 
structure-based engineering should be adopted as the main driving force for the 
production of novel polyketides. This strategy is advantageous as it can be used to 
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produce a large number of novel polyketides from just a single substrate, through the 
control of the polyketide length extension and the chemistry of intramolecular 
cyclization (Figure 1.6). In fact, a recent report demonstrated that a mutant PKS 
identified from Aloe arborescens (OKS N222G) is able to catalyze the formation of a 
decaketide from ten units of malonyl-CoA, which is currently the longest polyketide 
known to exist (Shi et al, 2009). Future engineering approaches could be targeted 
towards the design of novel PKSs that are capable of synthesizing polyketides with 
even greater chain length. 
An extension to the project could also be targeted towards the synthesis of other 
natural product classes. The flavonoids or polyketides contribute only to a small group 
of natural-occurring plant metabolites and other natural products including the alkaloids 
and isoprenoids were all well documented to possess important biological activities. 
Hence, the combinatorial biosynthesis of novel natural products could be expanded by 
cloning key enzymes from other biosynthetic pathways and engineering them for the 
production of compounds with therapeutic potential (Dixon, 2001). 
In Chapter four, the directed evolution of orthologous AHL-lactonases MCP and 
GKL led to the identification of several mutants with enhanced activity towards many 
AHL derivatives. However, the catalytic efficiencies of these enzymes are still far from 








 and hence could undergo additional rounds of 
directed evolution to produce “catalytically perfect” enzymes. With its inherent 
thermostability and ease of purification, GKL would remains as an ideal template for 
future development into a more effective therapeutic agent. The recent identification 
and characterization of a metal-independent enzyme from the amidohydrolase 
superfamily suggests that GKL could be engineered into a metal-independent enzyme 
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to circumvent the problems associated with the inactive form of apo-GKL (Hobbs et al, 
2012). 
From the demonstration that the engineered enzymes can disrupt the biofilm of 
A. baumannii, these enzymes can be applied as a form of anti-virulence therapeutic on 
various surgical equipments to prevent the formation of bacterial biofilms. Some of 
these equipments also include catheters and implants, where their frequent usages are 
often linked to an increase in the incidence of nosocomial-based infection. Hence, 
appropriate immobilization strategies could be used to coat these enzymes onto the 
surface of these equipments to prevent the formation of biofilm caused by nosocomial-
related pathogens. 
Although the use of broad spectrum drugs had always been the prefer choice of 
treatment for diseases, the rapid emergence of antibiotic-resistant pathogens had now 
favored the development of drugs which are more specific and narrow-spectrum. A 
good example would be the recent identification of an anti-microbial compound with 
good potency against the various Staphylococcal spp. (Haydon et al, 2008). 
Development of combination therapies should also be favorable in the near future, 
given the successful examples of using amoxicillin/clavulanic acid and 
trimethoprim/sulfamethozazole combination antibiotics in the treatment of many 
bacterial-mediated diseases. Although the severity of bacterial-mediated diseases still 
lies ahead of us with great uncertainty, the continuous development of novel anti-
microbial therapeutic strategies will always provide us with a leading edge in facing the 
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Table 1. List of acids and corresponding CoA ligases used for the in vivo combinatorial 





















Figure 1. Mass spectrometry spectra of MS medium and spent-medium of rice plants. 






Figure 2. SDS-PAGE analysis of recombinant OsPKS, MCP and GKL. (M) Protein 
ladder. (S) Supernatant. (P) Pellet. (FT) Flowthrough. (W1-W2) Normal and stringent 








               
 
Figure 3. Mass spectrometry spectrum of HPLC-purified bisnoryangonin. 
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Figure 5. Wavelength scans of wild-type and various charge-transfer mutants of GKL. 
 
